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ABSTRACT 
Preeclampsia is associated with disproportionately high rates of neonatal 
mortality and morbidity. Both therapeutic and prophylactic interventions have been 
lacking and delivery of the placenta remains the only effective cure for this obstetrical 
complication. 
In study 1 we examined the association between prior induced abortion and 
preeclampsia among nulliparous women in the Medical Birth Register (MBR) of Finland 
from 1996-2010. Preeclampsia cases (n=12,650) and frequency matched controls 
(n=50,600) were linked with the Finnish Registry of Induced Abortions to collect data on 
any prior induced abortions (IA ), method of IA, and gestational age at the time of IA. 
History ofiA was associated with a decreased risk of preeclampsia (OR 0.89, 95% CI 
0.84, 0.95). The risk of preeclampsia decreased further with an increasing number of 
prior IA with decreased risks of 8%, 23%, and 26% for 1, 2, and 2:3 lAs, respectively. 
These associations become more protective after restricting the analysis to women with 
no history of spontaneous abmtion (SAB). Surgical abortions at 2:12 weeks were 
associated with the greatest reduction in risk of preeclampsia (OR 0.81 95% CI 0.61, 
1.06). Our study confirms previous findings of a protective effect of IA on risk of 
v 
preeclampsia and provides new information regarding method and gestational age of 
abortion in relation to preeclampsia risk. 
In study 2 we investigated the potential for a differential effect of placental 
abruption on preeclampsia, based on the gestational age at the time of abruption among 
parous women in the MBR of Finland from 1996-2010. Cases of preeclampsia (n=6,487) 
and frequency matched controls (n=25,948) were linked to the Hospital Discharge 
Registry (HDR) and MBR to ascertain data on prior placental abruption. Placental 
abruption was categorized as preterm (<37 weeks) or term (2:37 weeks). Preterm 
abruptions were associated with a two-fold increase in risk of preeclampsia (OR 2.18 
95% CI 1.45, 3.30). In contrast term placental abruption was not associated with 
preeclampsia. The association between preterm placental abruption and preeclampsia was 
further elevated among women with a history of preeclampsia. Associations with preterm 
abruption were also strengthened when the outcome was defined as early-onset 
preeclampsia (<34 weeks). Placental abruption in a prior pregnancy conferred a different 
risk of preeclampsia based on the gestational age of the abruption affected pregnancy. 
Lastly, in study 3 we examined the association between intrauterine device (IUD) 
use and preeclampsia among women in the United Kingdom' s Clinical Practice Research 
Database from 1993-2010. Data on IUD use was obtained from patient records for 2,837 
cases and 11 ,221 matched controls. Any prior IUD use was associated with a reduced risk 
of preeclampsia (OR 0.77 95% CI 0.61 , 0.98). Timing of removal in relation to the start 
of pregnancy showed an inverse association, with shorter intervals associated with the 
largest decreases in risk of preeclampsia. IUD removal within a year prior to pregnancy 
Vl 
had an OR of 0.66 (95% CI 0.46, 0.96). Associations were most notable for women with 
a BMI <25kg/m2 and for women with no prior births. IUD use prior to pregnancy was 
associated with a reduced risk of preeclampsia, which was most apparent for those using 
an IUD within a year prior to pregnancy. 
Vll 
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1 INTRODUCTION 
Preeclampsia, the de novo onset of hypertension and proteinuria after the 20th 
week in gestation, complicates approximately 2-8% ofpregnancies 1-3 and is implicated in 
about 50,000 maternal deaths worldwide.4 It is associated with disproportionately high 
rates of stillbirth, neonatal mortality and infant morbidity. 5•6 Both therapeutic and 
prophylactic interventions to treat the syndrome of preeclampsia have been 
disappointing, and delivery of the placenta remains the only effective cure from this 
serious, debilitating, obstetrical complication. Even after the delivery of the placenta, 
women with preeclampsia experience a three-fold increase in risk of persistent 
hypertension throughout their post-reproductive life. 7 
Preeclampsia is directly implicated in one-quarter of all medically indicated 
preterm deliveries in the United States.8'9 In addition to preterm delivery, preeclampsia is 
associated with fetal growth restriction, placental abruption, fetal distress, and maternal 
mortality. Recent evidence suggests preeclampsia also contributes to long-term adverse 
outcomes in both mother and offspring.10-13 Despite its contribution to maternal and 
offspring morbidity and mortality, the etiology of preeclampsia remains obscure. 
Previously identified risk factors for preeclampsia include nulliparity, long 
interval between pregnancies, overweight and obesity, multiple gestations, and specific 
chronic health conditions, including pre-existing diabetes and hypertension. The strongest 
risk factor for preeclampsia is a previous pregnancy affected by preeclampsia, with an 
approximate seven-fold increase in risk.14 It has been hypothesized that preeclampsia is 
largely a fetal condition, predisposing to a maternal systemic inflammatory response to 
pregnancy, in which the placenta is viewed as an antigenic agent. 15 Understanding the 
1 
cascade of events that lead to such a response is a topic of much debate. Cases of 
preeclampsia are characterized by impaired or inadequate uterine vascular remodeling by 
placental trophoblast cells, in which the cells do not adequately invade the maternal spiral 
arteries, thereby impairing placental perfusion.9•16 There is evidence that some level of 
decidual injury actually increases the invasion potential of trophoblastic cells. 17 In 
clinical practice, women using assisted reproductive techniques have a higher success of 
implantation if endometrial injury, such as biopsy or curettage, occurred in the previous 
cycle.18 It is possible that previous injury in essence 'primes' the endometrium to be more 
receptive to pregnancy. A limited number of studies exist regarding prior insult to the 
endometrium as a mechanism to reduce the future immune response and consequently 
reduce the risk of preeclampsia. 
This doctoral thesis is aimed at exploring reproductive history events, specifically 
1) induced abortions, 2) placental abruption, and 3) intrauterine device usage, that cause 
endometrial injury, defined as a procedure or event that temporarily or permanently alters 
the structure and function of the endometrium or disrupts its homeostasis, and their role 
in reducing the risk of preeclampsia. 
2 
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2 INDUCED ABORTIONS AND THE RISK OF PREECLAMPSIA AMONG 
NULLIPAROUS WOMEN 
2.1 INTRODUCTION 
Preeclampsia is estimated to affect 4-8% of first pregnancies. The prevalence in 
subsequent pregnancies is 2 to 4 times lower. 1•2 Among several hypotheses to explain this 
decrease in risk is that spiral artery remodeling that occurs during pregnancy creates 
favorable conditions for subsequent pregnancies.3 Determining whether the decrease in 
risk from a first to a second pregnancy is restricted to women with a prior live birth or if 
any prior pregnancy, regardless of outcome, confers similar protection has been the topic 
of several studies. 
A history of abortion has been associated with a decreased risk of preeclampsia in 
several studies.4-7 Studies that have distinguished between spontaneous abortion (SAB) 
and induced abortion (lA) have reported a reduced risk of subsequent preeclampsia for 
IA, but not SAB,8•9 although findings have been inconsistent. 10 Similarly, the risk of 
preeclampsia decreases further with an increase in number of lAs, with an approximate 
13% risk reduction for one previous lA and a 61% risk reduction for two or more 
previous IAs,9 whereas no associations were detected between two or more SABs and the 
. k f 1 . II ns o preec ampsta. 
The mechanism through which an IA may protect against risk of preeclampsia 
remains unclear. lAs comprise a heterogeneous group of procedures using surgical 
methods (i.e. vacuum aspiration and dilation and evacuation) or medical methods (i.e. 
prostaglandins, mifepristone, and methotrexate). In addition to the type of procedure 
5 
performed, the timing of abortion is variable. One study to date reported a reduction in 
the risk of preeclampsia as the gestational age at abortion increased, with abortions being 
performed in the second and third months in gestation associated with reductions of 50% 
and 70%, respectively. These estimates were based on small numbers and did not 
distinguish between SAB and IA. 6 The aim of this study was to investigate the 
association between IA and subsequent risk of preeclampsia and determine if this 
association differs based on method and timing of abortion. 
2.2 METHODS 
2.2.1 Source Population 
A nested case-control study within the Medical Birth Register (MBR) of Finland 
was conducted. The MBR is a population-based registry that was established in 1987 and 
collects data on all live births and stillbirths at ::::0:22 weeks' gestation or infants weighing 
::::0:500g. The MBR captures 99.9% of newborns in Finland, which improves to 100% after 
linkages with the Central Population Register and Cause of Death Register. The MBR 
includes data on demographic factors, reproductive history, and diseases and diagnoses 
during pregnancy and delivery. The validity of the majority of variables in the MBR 
ranges from 90%-100%, with quality improvements being implemented over time. 12 The 
source population for the present study was restricted to singleton deliveries among 
nulliparous women, or those with no prior pregnancy resulting in a delivery at ::::0:22 
weeks, from 1996-2010. Parturients with missing parity data were excluded (n= 1203 
6 
(0.1 %)).Approval for this study was obtained from the National Institute of Health and 
Welfare (THL ). 
2.2.2 Case Definition 
Preeclampsia is defined as repeated measurements of systolic blood pressure 
2:140mmHg and/or diastolic blood pressure 2:90mmHg accompanied by proteinuria 
(2:0.3g/day) at 20 weeks' gestation or later. Eclampsia, a more severe manifestation, is 
preeclampsia accompanied by seizures. Both preeclampsia and eclampsia were included 
in the case definition. HELLP syndrome, a variant of preeclampsia, and superimposed 
preeclampsia were also included.13 
Preeclampsia cases were identified using two sources; ( 1) the Hospital Discharge 
Register (HDR) and (2) the MBR. The HDR is one of the oldest hospital discharge 
registers with continuous nationwide coverage since 1967. 14 Data on inpatient visits in all 
hospitals is available since 1969. Outpatient surgical procedures were included in the 
HDR beginning in 1994 and outpatient visits to public hospitals were added in 1998. 
Starting in 2004, inpatient and outpatient labor and delivery conditions were recorded in 
the MBR. Cases were identified using ICD-10 codes (preeclampsia: 011, 014, and with 
seizures: 015) in the HDR (1996-2010) and the MBR (2004-2010). The MBR also 
includes information on hospitalization due to hypertension during pregnancy. While this 
may indicate the presence of preeclampsia, these were not considered cases if diagnosis 
codes did not confirm the condition. 
7 
Four control women whose deliveries were unaffected by preeclampsia, as 
confirmed by the absence of a diagnosis code, were randomly selected from the MBR 
and frequency-matched to cases on year of delivery. 
2.2.3 Induced Abortions 
Data on lA were obtained from the Registry of Induced Abortions (RIA). The 
RIA has collected data on abmtions performed since 1950, with computerized data 
available beginning in 1983. All hospitals and clinics performing abortions are required 
to report to the registry, which captures an estimated 99% of all procedures performed. 15 
Data on gestational age and procedure method are reported. 
Cases and control deliveries were linked to the RIA using a maternal personal 
identification code. Data on lAs (1987-2010) prior to the last menstrual period (LMP) 
were collected. The number of prior lAs was categorized as 0, 1, 2, or 2:3. Gestational age 
at the time of abortion was categorized as <12 or 2:12 weeks. Method of abortion was 
categorized as either surgical or medical. In addition, the interpregnancy interval (IPI) 
between most recent lA and the study pregnancy was calculated by subtracting the date 
of abortion procedure from the LMP of the study pregnancy. 
2.2.4 Covariates 
Data on maternal age, smoking during pregnancy, and antenatal visits, were 
obtained from the MBR. Marital status and other socioeconomic correlates were also 
collected. These data are recorded at the time of birth and incorporate information from 
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the prenatal care record. Pre-pregnancy height and weight, as measured by healthcare 
personnel, were included in the MBR beginning in 2004. Pre-pregnancy body mass index 
(BMI) was calculated by dividing weight in kilograms by height in meters squared and 
categorized as underweight (<18.5), nmmal weight (18.5-24.9), overweight (25-29 .9), 
and obese (2:30). Diagnoses of chronic hypertension and preexisting diabetes from 1987 
to 2010 were ascertained from the HDR. 
Data on SAB was collected from maternal self-report of prior SAB recorded in 
the MBR and procedure codes in the HDR. The HDR only includes information on 
inpatient care (1987 -201 0) and outpatient visits in public hospitals (1998-20 1 0), therefore 
we also used information from maternal self-report to capture information on prior SABs 
that would have been missed by the HDR. 
2.2.5 Statistical Analysis 
The distributions of covariates by case and control status were examined. 
Unadjusted odds ratios, adjusted odds ratios (aOR) and 95% confidence intervals (CI) 
were calculated using unconditional logistic regression to measure the association 
between prior lAs and risk of preeclampsia in the study pregnancy. Covariates assessed 
as potential confounders were identified a priori based on reported associations with 
induced abortion and preeclampsia and included maternal age (<20, 20-24, 25-29, 30-34, 
2:35 years) and smoking during pregnancy (yes, no, unknown). Chronic hypertension (yes 
or no) and preexisting diabetes (yes or no) were also assessed as confounders. Covariates 
included in the adjusted model were selected using a change in estimate approach. 
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Briefly, covariates that altered the odds ratio by at least 10% from the unadjusted 
estimate were retained in the adjusted model. None of the selected covariates changed the 
odds ratio by greater than 10%, therefore we present crude and fully adjusted models for 
completeness. 
Pre-pregnancy height and weight were not included in the MBR until 2004, 
therefore approximately half of the study population is missing data on BMI. Multiple 
imputation methods using 10 imputed datasets were used to impute missing BMI values. 
Variables that were correlated with BMI or missingness of BMI were used as predictor 
variables. These included birth year, maternal age, prenatal care, marital status, smoking 
during pregnancy, history of SAB, chronic hypertension and preexisting diabetes. 
Preeclampsia and history of IA were also included as predictor variables. Imputed BMI 
values were categorized and assessed as potential confounders. 
The association between gestational age and method of abortion and the risk of 
preeclampsia was investigated among women with one prior abortion, in order to 
distinguish between the effect of timing and method of abortion from number of 
abortions. The joint effect of gestational age and method was also assessed by 
investigating all combinations of gestational age and method using women with no prior 
abortion as the reference group. Lastly, IPI was explored in relation to preeclampsia as a 
continuous variable using restricted cubic spline regression models.16 
History of SAB was assessed as a potential effect modifier by stratification, to 
observe whether or not the association between lA and preeclampsia, differs by history of 
SAB. Among women with both a SAB and an IA, we also investigated the timing of the 
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IA relative to the SAB in relation to the risk of preeclampsia. 
A sensitivity analysis separating early-onset preeclampsia, defined as delivery at 
<34 weeks' gestation, and late-onset preeclampsia was conducted, as these have been 
suggested to be conditions with different underlying pathologies. 17 Other sensitivity 
analyses were conducted after removing controls that were hospitalized during pregnancy 
due to hypertension and removing women with chronic hypertension and preexisting 
diabetes. 
2.3 RESULTS 
Among the 349,861 singleton deliveries to nulliparous women from 1996 to 2010, 
12,650 cases of preeclampsia occurred, yielding overall population prevalence of 3 .6%. 
The prevalence of preeclampsia increased over the study period from 2.2% in 1996 to 
4.2% in 2010 (Figure 2.1). Compared to 50,600 randomly selected controls with the 
same distribution of birth year, cases were more likely to be 2:35 years old, overweight 
and obese and have chronic hypertension and preexisting diabetes. Controls were more 
likely to smoke during pregnancy, 17.4% compared to 14.2% of cases. There was little 
difference in distributions of socioeconomic and marital status between cases and 
controls (Table 2.1 ). Distributions of selected covariates among control women by prior 
IA are presented in Table 2.2. Mothers with a prior IA were more likely to be 2:35 years 
old, blue-collar, and cohabiting or single. They were also more likely to smoke during the 
study pregnancy. 
A prior IA was more common among controls, with 13.1% of controls having a 
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prior IA compared to 11.7% of cases. The aOR for the association between any prior IA 
and preeclampsia was 0.89 (95% CI 0.84, 0.95). Increasing number of lAs was associated 
with corresponding greater reductions in risk of preeclampsia. Women with 1, 2, and~ 3 
prior lAs had aORs of0.92 (CI 0.86, 0.98), 0.77 (CI 0.65, 0.93), and 0.74 (CI 0.53, 1.04), 
respectively compared to women without any prior IA (Table 2.3). 
Restricting the analysis to women with one prior IA, we investigated the 
associations between gestational age at the time of abortion and procedure method in 
relation to preeclampsia (Table 2.4). Abortions performed at ~12 weeks (aOR 0.84, 95% 
CI 0. 69, 1. 0 1) were associated with a greater reduction in risk of preeclampsia than those 
performed at <12 weeks (aOR 0.92, 95% CI 0.86, 0.99) when both were compared to 
women without a prior IA, although the difference was not large and the confidence 
intervals overlapped. There was little difference in the risk of preeclampsia based on 
method of abortion. In evaluation of the combination of timing and method, surgical 
abortions at ~12 weeks were associated with the greatest reduction in risk of 
preeclampsia (aOR 0.81, 95% CI 0.61, 1.06). 
The association between IPI and risk of preeclampsia was investigated using 
spline regression models. The test for curvature of the spline plot was non-significant (p-
value=0.3) (Figure 2.2a), therefore the linear plot is also displayed (Figure 2.2b) . Among 
women with a prior lA, an IPI of < 1 year is associated with a reduced risk, while a 
longer IPI increases the risk of preeclampsia, compared to a referent value of 1 year 
(OR=1). 
Stratification by history of SAB showed effect measure modification, with IA 
12 
being associated with a reduced risk of preeclampsia only in the absence of a history of 
SAB (Table 2.5). The odds ratio for at least 3 prior lAs and preeclampsia was 0.66 (95% 
CI 0.43 , 1.00). Among women with a history of SAB, this association was null (aOR 
0.98, 95% CI 0.52, 1.72). Compared to women with no history of either a SAB or lA, the 
aOR for women experiencing a SAB before an lA was 0.89 (CI 0.63 , 1.26). If the SAB 
was after the lA this estimate attenuated slightly to 0.94 (CI 0.79, 1.11) (Table 2.6). 
Nearly 10% of cases were classified as early-onset preeclampsia using a <34 
week criterion. Associations were similar between early-onset preeclampsia (aOR 0.85; 
95% Cl 0.71 , 1.03) and late-onset preeclampsia (aOR 0.90; 95% Cl 0.84, 0.96) (Table 
2.7). 
Among controls, 3% (n=1558) were hospitalized for hypertension during 
pregnancy. The results of the sensitivity analysis removing these controls are presented in 
Table 2.8. Results for any lA and number ofiAs did not materially change compared to 
the primary analysis . Removing women with chronic hypertension and preexisting 
diabetes (3 .3% of cases and 0. 7% of controls), did not alter the results either (Table 2.9). 
2.4 DISCUSSION 
A history of lA was associated with a decreased risk of preeclampsia among 
nulliparous women. This risk further declined with increasing number of prior lAs from 
ORs of0.92 (95% Cl 0.84, 0.95) for 1 prior lA to 0.74 (95% Cl 0.53, 1.04) for women 
with 2:3 lAs. The risk of preeclampsia among nulliparous women with a prior IA was 
3.3%, which decreased to 2.7% for women with 2:3 lAs. This is still approximately 2 fold 
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higher than the risk of 1.3% among multiparous women in Finland. The protection 
against preeclampsia conferred by a prior IA did not equate to that of a previous birth. 
Our findings are consistent with other studies reporting a reduced risk of preeclampsia 
after an IA,6•8•9 and a greater reduction in risk for multiple IAs.9 Another study reported 
an increasing risk of preeclampsia with an increasing number of abortions, but this 
discrepancy may be explained by their inclusion ofboth SABs and IAs.7 In the present 
study, spontaneous abortions accounted for just over half of all prior abortions, which is 
similar to a Norwegian study among nulliparous women.9 
We report slight differences in risk based on timing ofiA, with those performed 
at 2:12 weeks being associated with a greater decrease in subsequent risk of preeclampsia 
than those performed at <12 weeks. Later timing of abortion has previously been 
associated with a decreased risk of preeclampsia,6 but not consistently. 18 Distinctions 
between SAB and IA were not made in these studies. To our knowledge, this is the first 
study to describe the association between timing of IA, specifically, and risk of 
preeclampsia. Differences between method of abortion were less apparent in the present 
study, which is consistent with a study that reported no difference in the incidence of 
preeclampsia between women with a prior mifepristone abortion and a prior surgical 
abortion. 19 A meta-analysis of subsequent pregnancy outcomes after medical abortion 
compared to surgical abortion reported an odds ratio of 0.74 (95% CI 0.50, 1.01) for 
pregnancy-induced hypertension syndrome. 20 The outcome of pregnancy-induced 
hypertension is not clearly explained and may include conditions other than 
preeclampsia, which may explain the observed differences. With the approval of 
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mifepristone (RU486) for first-trimester medical abortions in the several countries in the 
late 1990s and early 2000s, medical abortions account for an increasing proportion of 
procedures. In Finland, medical abortions have been available since 2000, and as of 2010 
accounted for 87% of all lAs performed, making surgical abortions increasingly rare? 1 
In the evaluation of combination of timing and method, surgical abortions at 2 12 
weeks were associated with the greatest decrease in the risk of preeclampsia. It is 
possible that both later abortions and surgical abortions are associated with higher degree 
of endometrial injury and subsequent spiral artery remodeling which may be in the 
pathogenic pathway for preeclampsia. Decidual injury has been observed to increase the 
invasion potential of trophoblastic cells,22 which are frequently impaired in cases of 
preeclampsia leading to the characteristic placental underperfusion. 23•24 It has been 
demonstrated that the local endometrial injury induces an inflammatory response that 
facilitates implantation.25 In clinical practice, women using assisted reproductive 
techniques have a higher success of implantation if endometrial injury, such as biopsy or 
d . h . 1 26 27 v . . h b . d . curettage, occurre m t e previOus eye e. ' acuum aspiratiOn as een associate with 
some amount of endo-myometrial injury, but other surgical and medical procedures 
haven't been studied?8 We speculate that the endometrial injury caused by an IA induces 
an inflammatory response that improves placentation and consequently reduces the risk 
of preeclampsia. Furthermore the reduction in preeclampsia risk was greatest among 
women whose IA occurred within a year of their LMP of the study pregnancy. It is 
possible that as repair processes occur, the immune response subsides, and the benefit of 
endometrial injury lessens over time. 
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Other hypothesized mechanisms of preeclampsia are also consistent with an 
increased risk of preeclampsia as IPI lengthens. The gradual increase in risk of 
preeclampsia with increasing IPI may be explained by the increasing likelihood of partner 
change. The protective effect of a prior abortion has been limited to pregnancies with the 
same paternity in studies of any abortion,29 and IA.9 The protective effect ofiA on 
subsequent preeclampsia was most apparent among women without a history of SAB. 
One other study reported no association between a history ofboth IA and SAB and 
preeclampsia, although abortion data was self-reported and findings were based on just 2 
exposed cases. 6 The mechanism by which IA would reduce the risk of subsequent 
preeclampsia only in the absence of a history of SAB warrants further examination, but 
some suggest sub-fecundity underlies both SAB and preeclampsia. The increasing 
likelihood of sub-fecundity with long IPis could offer some explanation for our findings . 
2.4.1 Limitations of the Data 
This study is not without limitations. It should be noted that medical abortions 
requiring subsequent (or post-IA) surgical evacuation procedures were not captured. 
While the proportion of women requiring a surgical procedure after a medical IA was 
estimated to be 6% in another Finnish study,30 it may have resulted in some 
misclassification of abortion method thereby attenuating the true odds ratios . 
Misclassification of prior SAB is also likely. While Finland lacks a registry for SABs, 
information on prior SAB was captured using two sources; procedure codes from the 
HDR and maternal self-report at the time of delivery of the index pregnancy recorded in 
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the MBR. Using both sources, 14.6% of nulliparous women had a prior SAB. This is 
similar to another observational study that reported 15 .2%,9 but less than that of studies 
using clinical methods to detect early losses. It is likely that early losses, including those 
occurring prior to clinical recognition, were those not captured in this study. 
Preeclampsia case ascertainment relied on recorded diagnostic codes in the HDR and 
MBR. While the specificity of diagnostic codes for preeclampsia in the registries is 
expected to be high, reducing the likelihood of false positives, the sensitivity of 
preeclampsia diagnoses in other hospital discharge datasets is reported to range from 70-
88%.31'32 We assessed the possibility that true cases were included as controls, by 
performing a sensitivity analysis that removed controls with pregnancy-hypertension. The 
results did not alter conclusions. Lastly, lack of information on partner change is a 
limitation of the present study. 
2.4.2 Strengths of the Data 
Strengths of this study include the large sample size, the use of nation-wide 
registers, and detailed information on timing and method ofiA. Nearly 13,000 cases of 
preeclampsia among nulliparous women were included in this analysis . Cases and 
controls were ascertained from a nation-wide registry that captures all births in the 
country thereby reducing the potential for selection bias. The Finnish Registry of Induced 
Abortions has collected information from medical providers since 1950 and is estimated 
to be 99% complete. 15 Furthermore the validity of several variables recorded in the RIA 
has been demonstrated to be high. The use of the registry for information on lAs in our 
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study offers a major improvement over previous studies that have relied on self-reported 
data, thereby reducing the likelihood of exposure misclassification. Information on 
several covariates was also collected using sources that do not rely on self-report. 
2.5 CONCLUSIONS 
An increased number of lAs and second-trimester surgical abortions were 
associated with the greatest reduction in risk of preeclampsia. Additionally, the effect of 
IA was only apparent among women without a prior SAB. While we present support for 
the hypothesis that endometrial injury associated with lAs, most specifically, second-
trimester surgical abortions, decreases the subsequent risk of preeclampsia, we cannot 
rule out other explanations. Studies designed to disentangle the effects of timing, method, 
and number of prior lAs are needed to further our understanding of the pathogenesis of 
preeclampsia. 
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2.7 TABLES 
Table 2.1 Distribution of Characteristics of Preeclampsia Cases and Controls, Medical 
Birth Register of Finland, 1996-2010 
Preeclampsia Cases Controls 
n=12,650 n=50,600 
n o;o n o;o 
Maternal age 
<20 631 5.0 3105 6.1 
20-24 2912 23.0 12467 24.6 
25-29 4401 34.8 18478 36.5 
30-34 3024 23.9 11857 23.4 
2:35 1682 13.3 4693 9.3 
Mean (SO) 28.0 5.5 27.3 5.2 
Body-mass index (kg/m2) 3 
Underweight ( <18.5) 190 2.7 1234 4.4 
Normal (18.5-24.9) 3509 50.3 17320 62.0 
Overweight (25-29.9) 1485 21.3 4903 17.6 
Obese (2:30) 1167 16.7 2362 8.5 
Missing 629 9.0 2101 7.5 
Mean (SO) 25.37 5.4 23.71 4.5 
Socioeconomic status 
Upper white-collar 2131 16.8 8934 17.7 
Lower white-collar 4632 36.6 16936 33.5 
Blue collar 1839 14.5 7120 14.1 
Student 1552 12.3 7151 14.1 
Otherb 382 3.0 1521 3.0 
Unknown 2114 16.7 8938 17.7 
22 
Marital status 
Married 5969 47.2 23451 46.3 
Cohabiting 4865 38.5 19547 38 .6 
Single 1785 14.1 7471 14.8 
Unknown 31 0.2 131 0.3 
Smoked during pregnancy 
Yes 1790 14.2 8801 17.4 
Unknown 294 2.3 1003 2.0 
Prenatal visits 
<15 3188 25.2 15184 30.0 
15-19 4585 36.2 22800 45.1 
2:20 4593 36.3 11819 23.4 
Unknown 284 2.2 797 1.6 
Mean (SD) 18.57 7.2 17.05 5.4 
History of spontaneous 
abortionc 1897 15.0 7307 14.4 
Chronic hypertensionc 84 0.7 73 0.1 
Pre-existing diabetesc 334 2.6 276 0.5 
a Available beginning in 2004 
bOther includes entrepreneur, farmer, unemployed, self-employed, and housemother 
c Ascertained from 1987-2010 
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Table 2.2 Distribution of Characteristics by Prior Induced Abortion among Control 
Subjects, 1996-2010 
No Prior 
Prior Induced Abortion Abortion 
n=6,604 n=43,996 
n 0/o n % 
Maternal age 
< 20 399 6.0 2706 6.2 
20-24 1722 26.1 10745 24.4 
25-29 2118 32.1 16360 37.2 
30-34 1545 23.4 10312 23.4 
2: 35 820 12.4 3873 8.8 
Body-mass index (kg/m2) 3 
Underweight (<18 .5) 154 4.3 1080 4.4 
Normal (18.5-24.9) 2124 58.9 15196 62.5 
Overweight (25-29.9) 653 18.1 4250 17.5 
Obese (2:30) 339 9.4 2023 8.3 
Missing 337 9.3 1764 7.3 
Socioeconomic status 
Upper white-collar 794 12.0 8140 18.5 
Lower white-collar 2237 33.9 14699 33.4 
Blue collar 1312 19.9 5808 13.2 
Student 891 13 .5 6260 14.2 
Otherb 203 3.1 1318 3.0 
Unknown 1167 17.7 7771 17.7 
Marital status 
Married 1948 29.5 21503 48.9 
Cohabiting 3205 48 .5 16342 37.1 
Single 1430 21.7 6041 13.7 
Unknown 21 0.3 110 0.3 
24 
Smoked during pregnancy 
Yes 2114 32.0 6687 15.2 
Missing 130 2.0 873 2.0 
Antenatal visits 
<15 1926 29.2 13258 30.1 
15-19 3026 45.8 19774 44.9 
2:20 1547 23.4 10272 23.3 
Missing 105 1.6 692 1.6 
History of spontaneous 
abortionc 1330 20.1 5977 13.6 
Chronic hypertensionc 12 0.2 60 0.1 
Pre-existing diabetesc 39 0.6 237 0.5 
a Available beginning in 2004 
bOther includes entrepreneur, fanner, unemployed, self-employed, and housemother 
c Ascertained from 1987-2010 
25 
N 
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Table 2.3 Association between Any Prior Induced Abortion and Number of Prior Induced Abortions and Preeclampsia 
Controls Preeclampsia 
Cases (n=12,650) (n=50,600) 
Odds Ratio (95% Confidence Interval) for Preeclampsia 
n 0/o n 0/o Unadjusted Adjusted a 
Prior Induced Abortion 
No 11164 88.3 43996 86.9 1.0 (Reference) 1.0 (Reference) 
Yes 1486 11.7 6604 13.1 0.89 (0.84, 0.94) 0.89 (0.84, 0.95) 
Number of Prior Induced Abortions 
1 1283 10.1 5557 11.0 0.91 (0.85, 0.97) 0.91 (0.86, 0.98) 
2 161 1.3 821 1.6 0.77 (0.65, 0.92) 0.77 (0.64, 0.91) 
~3 42 0.3 226 0.4 0.73 (0.53, 1.02) 0.74 (0.53, 1.03) 
a Adjusted for maternal age, smoking during pregnancy, chronic hypertension and preexisting diabetes 
b Adjusted for covariates in model (a) and imputed BMI 
Adjustedb 
1. 0 (Reference) 
0.89 (0.84, 0.95) 
0.92 (0.86, 0.98) 
0.77 (0.65, 0.93) 
0.74 (0.53, 1.04) 
N 
-.J 
Table 2.4 Association between Timing and Method oflnduced Abortion and Preeclampsia, Restricted to Women with One 
Prior Induced Abortion 
Preeclampsia 
Cases (n=l2447) 
n 
Timing of Abortion (gestational weeks) 
<12 1141 9.2 
2:12 142 1.1 
Method 
Surgical 1012 8.1 
Medical 271 2.2 
Timing and Method 
<12, Surgical 944 7.6 
<12, Medical 197 1.6 
2:12, Surgical 68 0.5 
2: 12, Medical 74 0.6 
No Induced Abortion 11164 89.7 
Controls 
(n=49553) 
n % 
4903 9.9 
654 1.3 
4388 8.9 
1161 2.3 
4059 8.2 
841 1.7 
329 0.7 
320 0.6 
43996 88.8 
Odds Ratio (95% Confidence Interval) 
for Preeclampsia 
Unadjusted Adjusted a 
0.89 (0.83, 0.96) 0.92 (0.86, 0.99) 
0.84 (0.68, 1.03) 0.84 (0.69, 1.01) 
0.91 (0.85 , 0.98) 0.91 (0.84, 0.97) 
0.92 (0.81 , 1.05) 0.95 (0.83, 1.09) 
0.92 (0.85, 0.99) 0.91 (0.85, 0.99) 
0.92 (0.79, 1.08) 0.98 (0.83 , 1.15) 
0.82 (0.63 , 1.06) 0.81 (0.61, 1.06) 
0.91 (0.71 , 1.17) 0.88 (0.68, 1.14) 
1. 0 (Reference) 1. 0 (Reference) 
a Adjusted for maternal age, smoking during pregnancy, chronic hypertension, and preexisting diabetes 
Table 2.5 Association between Any and Number of Prior Induced Abortions and Preeclampsia, Stratified by History of 
Spontaneous Abortion 
No History of Spontaneous Abortion History of Spontaneous Abortion 
Cases Controls Adjusted ORa Cases Controls Adjusted ORa 
n=10,753 n=43,293 (95% Cl) n=1,897 n=7,307 (95% Cl) 
n (%) n(%) n (%) n(%) 
Any Induced Abortions 
No 9605 (89.3) 38019 (87.8) 1.0 (Reference) 1559 (82.2) 5977 (81.8) 1. 0 (Reference) 
Yes 1148 (10.7) 5274 (12.2) 0.86 (0.81, 0.93) 338 (17.8) 1330 (18.2) 1.00 (0.87, 1.15) 
Number of Induced Abortions 
1 1005 (9.3) 4501 (10.4) 0.89 (0.82, 0.96) 278 (14.7) 1056 (14.5) 1.03 (0.88, 1.19) 
N 
00 2 115(1.1) 607 (1.4) 0.74 (0.60, 0.92) 46 (2.4) 214 (2.9) 0.88 (0.63, 1.23) 
2:3 28 (0.3) 166 (0.4) 0.66 (0.43, 1.00) 14 (0.7) 60 (0.8) 0.98 (0.52, 1.72) 
a Adjusted for maternal age, smoking during pregnancy, imputed BMI, chronic hypertension, and preexisting diabetes 
Table 2.6 Association between the Order of Induced and Spontaneous Abortions and the Risk of Preeclampsia 
Preeclampsia Controls Crude OR Adjusted ORa 
Cases (n=l2,527) (n=50,149) (95% CI) (95% CI) 
n n Unadjusted Adjusted3 
Abortion History 
lA and SAB 338 2.7 1330 2.7 1.01 (0.89, 1.14) 0.98 (0.87, 1.11) 
IA before SAB 171 1.4 701 1.4 0.97 (0.82, 1.14) 0.94 (0.79, 1.11) 
SAB before IA 44 0.4 178 0.4 0.98 (0.70, 1.36) 0.89 (0.63 , 1.26) 
lA Only 1148 9.2 5274 10.5 0.86 (0.81 , 0.92) 0.86 (0.80, 0.93) 
N SAB Only 1559 12.4 5977 11.9 1.03 (0.97, 1.10) 0.99 (0.93 , 1.05) 
\0 
No SAB or lA 9605 76.7 38019 75 .8 1. 00 (Reference) 1. 00 (Reference) 
a Adjusted for maternal age, smoking during pregnancy, chronic hypertension, and preexisting diabetes 
w 
0 
Table 2.7 Association between Induced Abortions and Early-Onset (<34 weeks) and Late-Onset Preeclampsia (~34 weeks) 
Early Onset Preeclampsia (<34 weeks) Late Onset Preeclampsia (~34 weeks) 
Early Onset 
Preeclampsia 
(n=l,216) 
n 
Odds Ratio (95% Confidence 
Interval) for Preeclampsia 
Unadjusted Adjusted a 
Any Prior Induced Abortion 
No 1074 88.3% 1. 00 (Reference) 1.00 (Reference) 
Yes 142 11.7% 0.88 (0.74, 1.05) 0.85 (0.71 , 1.03) 
Number of Prior Induced Abortions 
1 124 10.2% 0.92 (0.76, 1.10) 0.90 (0.74, 1.09) 
2 15 1.2% 0.75 (0.45, 1.25) 0.70 (0.41 , 1.19) 
~3 3 0.2% 0.54 (0.17, 1.70) 0.38 (0.09, 1.53) 
Late Onset 
Preeclampsia 
(n=l1,398) 
n 
10054 88.2% 
1344 11.8% 
1159 10.2% 
146 1.3% 
39 0.3% 
Odds Ratio (95% Confidence 
Interval) for Preeclampsia 
Unadjusted Adjusted a 
1. 00 (Reference) 1. 00 (Reference) 
0.89 (0.84, 0.95) 0.90 (0.84, 0.96) 
0.91 (0.85 , 0.98) 0.92 (0.86, 0.98) 
0.78 (0.65, 0.93) 0.78 (0.65, 0.93) 
0.76 (0.54, 1.06) 0.79 (0.56, 1.11) 
a Adjusted for maternal age, smoking during pregnancy, imputed BMI, chronic hypertension and pre-existing diabetes 
w 
........ 
Table 2.8 Association between Induced Abortion and Preeclampsia, Removing Controls Hospitalized for Pregnancy-
Hypertension 
Any Induced Abortions 
No 
Yes 
Preeclampsia Cases 
(n=l2,650) 
n 
11164 
1486 
88.3 
11.7 
Number of Induced Abortions 
1 
2 
~3 
1283 
161 
42 
10.1 
1.3 
0.3 
n 
42606 
6436 
5410 
802 
224 
Controls 
(n=49,042) 
86.9 
13 .1 
11.0 
1.6 
0.5 
Odds Ratio (95% Confidence Interval) for 
Preeclampsia 
Unadjusted 
1. 00 (Reference) 
0.88 (0.83 , 0.94) 
0.91 (0.85, 0.97) 
0.77 (0.65, 0.91) 
0.72 (0.51 , 1.00) 
Adjusted3 
1.00 (Reference) 
0.88 (0.83 , 0.94) 
0.91 (0.85 , 0.97) 
0.77 (0.64, 0.91) 
0.71 (0.50, 1.00) 
a Adjusted for maternal age, smoking during pregnancy, imputed BMI, chronic hypertension and pre-existing diabetes 
Table 2.9 Association between Induced Abortions and Preeclampsia, Removing Women with Chronic Hypertension or 
Preexisting Diabetes 
Any Induced Abortions 
No 
Yes 
Preeclampsia Cases 
(n=12,238) 
n 
10809 
1429 
88.3 
11.7 
Number of Induced Abortions 
1 
2 
2:3 
1234 
157 
38 
10.1 
1.3 
0.3 
Controls 
(n=50,256) 
n 
43700 
6556 
5513 
817 . 
226 
o/o 
87.0 
13.0 
11.0 
1.6 
0.4 
a Adjusted for maternal age, smoking during pregnancy, and imputed BMI 
Odds Ratio (95 % Confidence Interval) 
for Preeclampsia 
Unadjusted 
1. 00 (Reference) 
0.88 (0.83, 0.94) 
0.91 (0.85 , 0.97) 
0.78 (0.65 , 0.92) 
0.68 (0.48, 0.96) 
Adjusted3 
1. 00 (Reference) 
0.89 (0.83, 0.94) 
0.91 (0.85 , 0.97) 
0.77 (0.65 , 0.92) 
0.69 (0.49, 0.99) 
(.;..) 
(.;..) 
2.8 FIGURES 
Figure 2.1 Risk of Preeclampsia by Year of Delivery, Medical Birth Register and Hospital Discharge Register of Finland, 
1996-2010 
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Figure 2.2 Spline Regression Plot (a) and Linear Plot (b) for the Association between Interpregnancy Interval and Odds of 
Preeclampsia among Women with Induced Abortion(s) 
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3 PLACENTAL ABRUPTION AND SUBSEQUENT RISK OF PREECLAMPSIA 
3.1 INTRODUCTION 
Preeclampsia is one of three conditions that constitute the syndrome of ischemic 
placental disease (IPD), a group of pathologies that also includes placental abruption and 
intrauterine growth restriction (IUGR). 1 A common etiology involving poor placentation 
in early pregnancy or excessive premature placental detachment has been proposed as 
underlying mechanisms leading to the characteristic uteroplacental underperfusion or 
ischemia of these obstetrical complications? IPD in a prior pregnancy is a risk factor for 
IPD in a subsequent pregnancy.3•4 While the recurrence ofiPD has been well 
documented, there is little known about the recurrence of such diseases based on preterm 
and term gestations. Recent evidence suggests that the causative pattern of IPD differs 
with respect to preterm and term gestations, with the underpinnings of ischemic placental 
diseases being more homogeneous at preterm than term gestations. 1 
In the United States the rate ofabruption is 2.3% among preterm births (<37 
weeks) and 0.3% among term births, making preterm abruption 9 times more common.5 
One study found that mean birth weight and placental weight were lower in preterm 
abruption births compared to preterm non-abruption births, but among term abruption 
births no such association was observed, indicating that preterm abruption is more 
consistent with uteroplacental ischemia. 6 
Placental abruption in a prior pregnancy is associated with an approximate two-
fold increase in the risk of preeclampsia in a subsequent pregnancy. 3 It is not known if a 
different risk is conferred based on gestational timing of the placental abruption in an 
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earlier pregnancy. While both preterm and term placental abruption can cause 
endometrial injury, only preterm placental abruption is thought to share a common risk 
factor with preeclampsia. The aim of this study is to explore the association of placental 
abruption on the subsequent risk of preeclampsia in both the absence and presence of a 
common underlying etiology. 
3.2 METHODS 
3 .2.1 Source Population 
A nested case-control study within the Medical Birth Register (MBR) of Finland 
was conducted. The MBR is a population-based register that was established in 1987 and 
includes all live births and stillbirths of at least 22 weeks' gestation or having a birth 
weight of at least 500 g. The MBR captures 99.9% of deliveries in Finland, which is 
rendered complete after linkages with the Central Population Register and the Cause of 
Death Register. The MBR includes information on demographic factors, previous 
pregnancies, and diseases and diagnosis during pregnancy and delivery. The source 
population for this study was restricted to singleton deliveries in the MBR from 1996 to 
2010 among parous women, or those with at least one prior stillbirth or live birth. 
Women with missing data on parity were excluded (n=1203; 0.1 %). Approval for this 
study was obtained from the National Institute of Health and Welfare (THL). 
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3 .2.2 Case Definition 
Preeclampsia is defined as repeated measurements of systolic blood pressure 
2140mmHg and/or diastolic blood pressure 290mmHg accompanied by proteinuria 
(20.3g/day) at 20 weeks ' gestation or later. Eclampsia, a more severe manifestation, is 
preeclampsia accompanied by seizures. Both preeclampsia and eclampsia were included 
in the case definition. HELLP syndrome, characterized by hemolysis, elevated liver 
enzymes, and low platelet count, is considered a subtype of preeclampsia, and was also 
included. Superimposed preeclampsia was also included. 
Preeclampsia cases were identified using two sources; (1) the Hospital Discharge 
Register (HDR) and (2) the MBR. The HDR contains information on inpatient visits to 
public and private hospitals (since 1967) and outpatient visits in public hospitals (since 
1998). Struiing in 2004, inpatient and outpatient labor and delivery conditions were 
recorded in the MBR. Cases were identified using ICD-1 0 codes (preeclampsia: 011, 
014, and with seizures: 015) in the HDR (1996-2010) and the MBR (2004-2010). The 
MBR also includes data on hospitalization due to hypertension during pregnancy. While 
this may indicate the presence of preeclampsia, these were not considered cases if 
diagnosis codes did not confirm the condition. Among those hospitalized for 
hypertension during pregnancy, approximately 14% did not have a preeclampsia related 
diagnosis code. 
Four control deliveries from the MBR, as identified by the absence of a 
preeclampsia diagnosis code, were chosen for each case and frequency-matched on year 
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of birth. The unit of observation for this study was a unique delivery, therefore a woman 
could contribute multiple deliveries to the study. 
3.2.3 Placental Abruption 
Preeclampsia cases and frequency-matched controls were linked to the HDR 
using an encrypted maternal personal identity code to ascertain data on placental 
abruption in prior pregnancies. Diagnoses of placental abruption in the HDR were 
identified from 1987-2010, using ICD-9 coding (641.2) for years 1987-1995 and ICD-10 
coding (045) for years 1996-2010. This allowed for a minimum often years of 
reproductive history to be captured for all study subjects. A checkbox for placental 
abruption (1990-2005) and diagnosis codes (1987 -1989, 2004-201 0) included in the 
MBR were also used to identify placental abruptions. Occurrences of placental abruption 
were categorized by gestational age at the time of delivery. Preterm abruptions were 
those delivered at <37 weeks (259 days) and term abruptions were those at 37-41 weeks ' 
gestation. Placental abruptions occurring in the current pregnancy or subsequent 
pregnancies were not considered. 
3.2.4 Covariates 
Data on maternal demographic and reproductive characteristics including 
maternal age and parity were collected from the MBR. Information on prenatal care visits 
and smoking during pregnancy was also collected. These data were recorded at the time 
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of birth and incorporate information from the prenatal care record. Pre-pregnancy height 
and weight, as measured by healthcare personnel, were included in the MBR beginning in 
2004. Pre-pregnancy body mass index (BMI) was calculated by dividing weight in 
kilograms by height in meters squared. Pre-pregnancy BMI was categorized as 
underweight (<18.5), normal weight (18.5-24.9), overweight (25-29.9), and obese (2:30). 
History of induced abortion (1987 -201 0) was obtained through a record linkage 
with the Registry of Induced Abortions (RIA), data available in electronic format since 
1983. History of spontaneous abortion (1987-2010) was collected from the HDR and 
maternal self-report in the MBR. Both spontaneous and induced abortions were 
categorized as any history or no known history. History of preeclampsia (1987 -201 0) was 
collected using ICD-9 codes (1987-1995) and ICD-10 codes (1996-2010) from the HDR 
and ICD-10 codes (2004-2010) in the MBR. 
3.2.5 Statistical Analysis 
The distributions of covariates by case status were calculated. Unconditional 
logistic regression models were used to calculate unadjusted and adjusted odds ratios 
(aOR) and 95% confidence intervals (CI) for any prior placental abruption, placental 
abruption in the immediately preceding pregnancy, and the risk of preeclampsia in a 
subsequent pregnancy. These associations were subsequently examined following 
stratification based on the gestational age at the diagnosis of abruption: preterrn versus 
term abruptions. Women with no prior placental abruption were used as the referent 
group. Since data on pre-pregnancy height and weight were not included in the MBR 
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until 2004, approximately half of the study population did not have data on BMI. 
Multiple imputation methods using 10 imputed datasets were used to impute missing 
BMI values. Variables that were correlated with BMI or missingness of BMI were used 
as predictor variables. These included birth year, maternal age, parity, prenatal care, 
smoking during pregnancy, history of spontaneous and induced abortion, and pre-existing 
hypertension and diabetes. Preeclampsia and prior preterm or term placental abruption 
were also included as predictor variables. Imputed BMI value was categorized and 
assessed as a potential confounder. 
Covariates assessed as potential confounders were identified a priori based on 
associations with both placental abruption7 and preeclampsia8 and included maternal age 
(<25, 25-29, 30-34 or ~35 years), parity (1 or ~2), smoking during pregnancy (yes, no, 
unknown), chronic hypertension (yes or no) and pre-existing diabetes (yes or no). A 
history of preeclampsia was also assessed as a potential confounder in both preterm and 
term models. Co variates that altered the odds ratio by at leastl 0% upon inclusion in the 
model were retained. History of preeclampsia was the only covariate that altered the odds 
ratio by at least 10%, so models adjusted for history of preeclampsia only, and models 
adjusted for all covariates identified a priori are presented. 
To investigate the association of history of preeclampsia on the association 
between placental abruption and subsequent preeclampsia, preterm and term abruptions 
were stratified by history of preeclampsia. Births were categorized as (1) preterm 
abruption with preeclampsia, (2) preterm abruption without preeclampsia, (3) term 
abruption with preeclampsia and (4) term abruption without preeclampsia. Women with 
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no prior abruption and no history of preeclampsia were used as the referent group. 
Additional analyses were performed after restricting to women whose most recent 
pregnancy outcome prior to the study pregnancy was a birth (stillbirth or live birth). Data 
on the immediately preceding birth (1987-2010) were collected from the MBR. 
Information on the preceding delivery, including gestational age and birth weight, was 
obtained for 96% of women. The following analyses were performed; (1) Stratification 
by inter-pregnancy interval (IPI). IPI was calculated as the time between the date of the 
immediately preceding birth and the date of the last menstrual period for the current 
pregnancy and categorized as <3 years or ~3 years . Intervals > 3 years have been 
associated with increases in risk of preeclampsia among parous women.9 (2) The joint 
effect of placental abruption with preterm delivery and small for gestational age (SGA) in 
the prior pregnancy and the subsequent risk of preeclampsia were assessed. Recently 
published population-based sex- and gestational age-specific references for birth weight 
in Finland were used to determine SGA, defined as birth weight more than 2 standard 
deviations below the sex- and gestational age-specific reference. 1° For purposes of this 
analysis all other infants were classified as appropriate for gestational age (AGA). Those 
with missing gestational age or birth weight were excluded (n=130). Women with no 
abruption and delivery at term of an AGA infant served as the universal reference group 
for these analyses. 
Preeclampsia is a heterogeneous condition, with differing pathologies suspected 
in the development of early onset and late onset disease. 11 An analysis was conducted to 
assess whether the effect of prior placental abruption conferred different effects with 
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respect to early-onset and late-onset preeclampsia. Hospital admission dates were only 
available for cases captured through the HDR, therefore gestational age at delivery of <34 
weeks was used to define early-onset preeclampsia. 
3.2.6 Sensitivity Analyses 
We performed a series of sensitivity analyses to corroborate the overall findings. 
These included the following. A sensitivity analysis was conducted to assess the 
association between placental abruption and incident preeclampsia. Incident cases were 
those without a history of preeclampsia, therefore women could only contribute one case 
delivery to this analysis. To assess the impact of outcome misclassification due to 
potential cases included in the control group, a second sensitivity analysis removing those 
with hypertension or hospitalization due to hypertension in pregnancy was conducted. 
Finally, a sensitivity analysis was performed using a cutoff of 35 weeks to capture 
preeclampsia cases that may have been early onset and delivered after the 34 weeks. 
3.3 RESULTS 
A total of 6,487 cases of preeclampsia occurred among parous women yielding an 
overall prevalence of 1.3% from 1996 to 2010. Compared to controls, cases were more 
likely to be ~35 years old (33.5% vs. 24.9%) and overweight (25 .3% vs. 21.5%) or obese 
(24.4% vs. 11.4%) prior to pregnancy. Cases were more likely to have ~20 antenatal 
visits and a history of preeclampsia. Pre-existing conditions, including hypertension and 
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diabetes, were also more prevalent among cases (Table 3.1 ). The distributions of 
co variates by prior placental abruption among control subjects are presented in Table 3 .2. 
Controls with a history of placental abruption were more likely to be older, have at least 
two prior pregnancies, and have a history of preeclampsia. They were also more likely to 
smoke during pregnancy compared to women without a history of placental abruption 
(21.4% vs. 12.9%). 
Placental abruption in any prior pregnancy was more common among 
preeclampsia cases than controls (1.0% vs. 0.5%; Table 3.3). This difference was driven 
by preterm placental abruption with 0.7% of cases and 0.2% of controls having a prior 
preterm abruption (OR 2.18; 95% CI 1.45, 3 .30). In contrast, term placental abruption 
was not associated with subsequent risk of preeclampsia (OR 1.12; 95% CI 0.68, 1.84). 
Additional adjustment for covariates and BMI (with missing BMI imputed) values did 
not materially change results. Restricting prior abruptions to only those occurring in the 
immediately preceding pregnancy yielded an increased odds ratio for the association 
between preterm abruption and preeclampsia (OR 2.78, 95% CI 1.62, 4.77). The estimate 
for term placental abruption remained unchanged. 
The association of abruption on subsequent risk of preeclampsia differed based on 
history of preeclampsia. Preterm abruption with a history of preeclampsia was associated 
with a 16-fold increased risk in subsequent preeclampsia (OR 16.57, 95% CI 5 .34, 
51.43). Among women without a history of preeclampsia, this association was reduced to 
a 2-fold increase. The odds ratio for term abruption and history of preeclampsia was 2.12, 
which attenuated to 1.35 for those without a history of preeclampsia (Table 3.4 ). 
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Of the 32,435 deliveries included in this analysis, data on the preceding delivery 
in the MBR was available for 31,035 women (95.7%). Among them, 26,587 (85.7%) had 
a live birth or stillbirth immediately before the study pregnancy, 3132 (1 0.1 %) had a 
spontaneous abortion, 1316 ( 4.2%) had an induced abortion between deliveries. Of those 
with an immediately preceding birth, the associations between placental abruption and 
preeclampsia differed based on IPI. Among women with an IPI <3 years, preterm 
abruption was associated with an increase in risk of subsequent preeclampsia (OR 3.59, 
95% CI 1.67, 7.71), while a slight, statistically insignificant reduction in risk was 
observed for term abruption (OR 0.86, 95% CI 0.29, 2.57), although this estimate was 
based on just six cases. Among those with an IPI ~3, preterm and term abruption were 
associated with odds ratios of2.14 and 1.72, respectively, for subsequent preeclampsia 
(Table 2.5). 
Among women with a prior birth we also assessed the joint effects of placental 
abruption, preterm delivery, and SGA in the prior delivery on subsequent risk of 
preeclampsia (Figure 3.1 ). Compared to term, non-SGA births unaffected by abruption, 
elevated odds ratios were observed for all combinations involving abruption, preterm 
birth, or SGA. Only a prior term abruption that was not SGA was associated with a point 
estimate below the null (OR 0.82, 95% CI 0.33, 2.00). 
Approximately 10% (n=676) of preeclampsia cases were classified as early-onset, 
defined as delivery before 34 weeks' gestation. Compared to late-onset cases, they were 
more likely to be ~35 years old and multiparous. They were also more likely to have a 
history of preeclampsia (20.3% vs. 16.3%) and have at least one prior spontaneous 
44 
abortion ( 41.0% vs. 32.5%). Preterm abruption was more strongly associated with early-
onset preeclampsia (OR 4.26, 95% CI 2.01 , 9.02) than late-onset preeclampsia (OR 2.01 
95% CI 1.25, 3.22). There was no association between prior term abruption and 
subsequent late-onset preeclampsia (OR 0.99, 95% CI 0.56, 1.76) (Table 3.6). Results 
were similar using a 35 week definition (data not shown). 
After removing 16.8% (n=1088) of cases and 3.1% (n=817) of controls with 
history of preeclampsia, the odds ratios for preterm and term abruption with incident 
preeclampsia were 2.04 (95% CI 1.25, 3.33) and 1.38 (95% CI 0.80, 2.39), respectively, 
which are similar to the results of the primary analysis (Table 3.7) The results of a 
sensitivity analysis which restricted controls to those without hospitalization due to 
hypertension in pregnancy were also not materially changed (Table 3.8). 
3.4 DISCUSSION 
Placental abruption in a previous pregnancy was associated with an increased risk 
of preeclampsia in a subsequent pregnancy. Our findings are similar to a prior study in 
the United States reporting an approximate 2-fold increased risk of preeclampsia for 
placental abruption.3 Upon distinguishing between preterm and term placental abruptions, 
the increased risk of preeclampsia was confined to preterm placental abruption. To our 
knowledge this is the first study to distinguish between preterm and term abruptions. 
Studies of preeclampsia as a risk factor for placental abruption, have distinguished 
between early-onset and late-onset preeclampsia and similarly reported larger relative 
risks of placental abruption for early-onset preeclampsia (RR: 2.3 and 2.4) than for late-
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onset preeclampsia (RR: 1.3). 12•13 It has been suggested that preterm and term placental 
abruption are heterogeneous conditions, with differing risk profiles and pathologies. 5 In 
addition to events preceding placental abruption, we demonstrated that events following 
placental abruption, specifically preeclampsia, differ by whether or not the placental 
abruption was preterm or term. 
In addition to the gestational timing of placental abruption, the gestational timing 
of preeclampsia also altered associations. There is accumulating evidence that early-onset 
preeclampsia and late-onset preeclampsia represent distinct conditions, with early-onset 
being more severe and having a larger genetic component. 11 •14 The association between 
placental abruption and preeclampsia was most notable when both the abruption and 
preeclampsia occurred early in gestation. Using a definition for early-onset preeclampsia 
of <34 weeks, preterm placental abruption was associated with a 4-fold increased risk of 
early-onset preeclampsia. While no other studies have explored the relationship between 
preterm placental abruption and early-onset preeclampsia, recurrence rates of 
preeclampsia are highest when both preeclampsia events are early-onset. 15 
Placental abruption and preeclampsia are both considered conditions of IPD. 
Recurrence within and across conditions ofiPD has been well established, l.3 therefore we 
explored the joint effect of placental abruption and preeclampsia in a prior pregnancy on 
the risk of subsequent preeclampsia. A history of pre term abruption coupled with 
preeclampsia increased the risk of preeclampsia to approximately 16-fold, which was 
much higher than expected under an additive model of the effects of placental abruption 
and preeclampsia alone, indicating biologic interaction between these two events and the 
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risk of preeclampsia. In addition to placental abruption and preeclampsia, SGA is another 
condition of IPD. Term abruptions with SGA were associated with a 6-fold increased risk 
of preeclampsia, while term abruptions without SGA showed no elevated risk. Term 
abruption, in the absence of other conditions ofiPD, was not associated with 
preeclampsia. 
In this study term placental abruption did not appreciably increase the risk of 
preeclampsia, providing support for theories suggesting that IPD is a disease confined to 
preterm gestations. While risk factors for preterm compared to term abruption have not 
been well elucidated, it is possible that risk factors unrelated to an ongoing pathology of 
placental ischemia, such as trauma and injury during pregnancy, account for a larger 
proportion of term abruptions. We hypothesized that in the absence ofuteroplacental 
ischemia, term abruptions may reduce the risk of subsequent preeclampsia. Endometrial 
injury has been shown to improve the invasion potential of trophoblastic cells, 16 
potentially through an inflammatory response that promotes improved implantation. 17•18 It 
may be extrapolated that the endometrial changes from placental abruption would 
improve subsequent trophoblastic cell invasion and placental perfusion and reduce the 
risk of preeclampsia, in the absence ofunderlying IPD. Term placental abruptions were 
not associated with a reduced risk of preeclampsia, except among those with shorter IPI 
(<3 years). Although this estimate was based on small numbers, it suggests that if there is 
any reduction in risk of preeclampsia due to term placental abruption the effect may be 
short-term and transient. 
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3.4.1 Limitations of the data 
The prevalence of preeclampsia among multiparous women in Finland is 1.3 %. 
This is similar to estimates from Sweden reporting 1. 7% among multiparous women 15 
and Norway reporting 1.4% among second pregnancies in women without a history of 
preeclampsia, 19 but less than the 2.8% observed among parous women in the United 
States?0 Differences in rates of preeclampsia may be due to differences in risk factor 
prevalence or diagnostic and recording practices. While the specificity of preeclampsia 
diagnostic codes recorded in hospital discharge datasets is approximately 90%, the 
sensitivity is less accurate (70-88%) allowing for the possibility that deliveries affected 
by preeclampsia were selected as controls?1•22 A sensitivity analysis excluding women 
that were hospitalized for hypertension in pregnancy yielded results that were largely 
similar to the overall findings, indicating that outcome misclassification is less likely to 
have been a source of bias. 
Diagnostic bias is of potential concern due to the possibility that women with 
prior pregnancy complications such as placental abruption may be followed more closely 
in subsequent pregnancies for the development of preeclampsia. In Finland access to 
prenatal care is universal and frequent. In 2011 , 99.7% of women in Finland received 
care with an average first visit at 9 weeks gestation and an average of 16 visits through 
the course ofpregnancy.23'24 Therefore we would expect the potential for diagnostic bias 
to be greatly reduced since nearly all women are closely monitored during pregnancy, 
regardless of obstetrical history. 
Another potential source of error is using the delivery date as a proxy for onset 
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date of placental abruption. Placental abruption is most frequently considered an 
obstetrical emergency, therefore delivery is likely a suitable marker for onset. Lastly, 
incomplete information on spontaneous abortions is likely. We included data from the 
HDR and maternal self-report to improve ascertainment of history of SAB, but early 
losses, especially those among pregnancies not yet clinically recognized would have been 
missed?5 While this limitation did not impact our overall findings, interpregnancy 
intervals may have been overestimated among women with missed SABs between 
pregnancies. 
3.4.2 Strengths ofthe data 
A strength of this study is use of the Finnish registry data. Data on both exposure 
and outcome as well as several covariate data were ascertained from the HDR and MBR 
and therefore eliminated reliance on self-reported data. Data in both the HDR and MBR 
has been validated and the recording of variables has generally been good, > 90% for 
many outcomes in the HDR and >99% for variables in the MBR.26-28 Additional strengths 
of this study included a large sample size, control for several co variates, and data 
linkages with unique personal identity codes available in all Finnish registers. Lastly, data 
on the prior birth was available for 96% of women, allowing for the ability to capture 
information on prior placental abruption for virtually all preeclampsia cases and controls. 
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3.5 CONCLUSIONS 
In conclusion, preterm placental abruption is associated with an increased risk of 
preeclampsia in a subsequent pregnancy. Associations were most pronounced among 
women with a history of ischemic placental disease in addition to placental abruption and 
among cases of early-onset preeclampsia. In contrast, term abruption, in the absence of 
any indication of IPD, was not associated with preeclampsia. Our findings support the 
notion that IPD may be a syndrome confined to preterm gestations, suggesting that the 
nomenclature of IPD should be reserved for particular cases of placental abruption and 
preeclampsia. Future work is needed to corroborate our findings and better characterize 
conditions of IPD. 
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3.7. TABLES 
Table 3.1 Distribution of Selected Characteristics of Preeclampsia Cases and Controls, 
Medical Birth Register of Finland, 1996-2010 
Preeclampsia Controls 
Cases (n=6,487) (n=25,948) 
n o;o n o;o 
Year of birth 
1996-2000 1726 26.6 6904 26.6 
2001 -2005 2238 34.5 8952 34.5 
2005-2010 2523 38.9 10092 38.9 
Maternal age (years) 
<25 496 7.6 2802 10.8 
25-29 1518 23.4 7383 28.5 
30-34 2303 35.5 9305 35 .9 
~35 2170 33.5 6458 24.9 
Previous deliveries 
3834 59.1 14758 56.9 
~2 2653 40.9 11190 43 .1 
Body-mass index (kg/m2) 8 
Underweight (<18.5) 51 1.4 441 3.1 
Normal (18.5 -24.9) 1411 40.0 8048 57.0 
Overweight (25 .0-29.9) 895 25 .3 3043 21.5 
Obese (~30.0) 861 24.4 1609 11.4 
Unknown 313 8.9 983 7.0 
Socioeconomic status 
Upper white-collar 953 14.7 4252 16.4 
Lower white-collar 2735 42.2 9808 37.8 
Blue collar 1038 16.0 4061 15.7 
54 
Other 582 9.0 2660 10.3 
Unknown 1179 18.2 5167 19.9 
Prenatal visits 
<15 1633 25.2 10290 39.7 
15-19 2257 34.8 10511 40.5 
2:20 2445 37.7 4726 18.2 
Unknown 152 2.3 421 1.6 
Smoked during pregnancy 
Yes 736 11.3 3351 12.9 
No 5547 85.5 21828 84.1 
Missing 204 3.1 769 3.0 
History of preeclampsiac 1088 16.8 817 3.1 
History of abortion 
Spontaneous abortionc 2162 33 .3 7649 29.5 
Induced abortionc 1090 16.8 4249 16.4 
Chronic hypertensionc 250 3.9 187 0.7 
Pre-existing diabetesc 140 2.2 116 0.4 
a Available beginning in 2004 
b Other includes entrepreneur, farmer, unemployed, self-employed, and housemother 
c Ascertained from 1987-2010 
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Table 3.2 Distribution of Characteristics by Prior Placental Abruption among Control 
Subjects, 1996-2010 
Maternal age (years) 
<25 
25-29 
30-34 
2:35 
Previous deliveries 
1 
2:2 
Body-mass index (kg/m2)a 
Underweight ( <18.5) 
Normal (18.5 -24.9) 
Overweight (25- 29.9) 
Obese (2: 30) 
Unknown 
Socioeconomic status 
Upper white-collar 
Lower white-collar 
Blue collar 
Otherb 
Unknown 
Prenatal visits 
<15 
15-19 
Prior Abruption 
n=140 
n 
9 6.4 
26 18.6 
53 37.9 
52 37.1 
50 35.7 
90 64.3 
2 2.6 
45 57.7 
11 14.1 
11 14.1 
9 11.5 
19 13.6 
58 41.4 
20 14.3 
10 7.1 
33 23.6 
50 35.7 
57 40.7 
56 
No Abruption 
n=25808 
n 
2793 10.8 
7357 28.5 
9252 35 .8 
6406 24.8 
14708 57.0 
11100 43 .0 
439 3.1 
8003 57.0 
3032 21.6 
1598 11.4 
974 6.9 
4233 16.4 
9750 37.8 
4041 15.7 
2650 10.3 
5134 19.9 
10240 39.7 
10454 40.5 
~20 31 22.1 4695 18.2 
Unknown 2 1.4 419 1.6 
Smoked during pregnancy 
Yes 30 21.4 3321 12.9 
No 103 73 .6 21725 84.2 
Missing 7 5.0 762 3.0 
History of preeclampsiac 10 7.1 807 3.1 
History of abortions 
Spontaneous abortionc 47 33 .6 7602 29.5 
Induced abortionc 31 22.1 4218 16.3 
Chronic hypertensionc 2 1.4 185 0.7 
Preexisting diabetesc 0 0.0 116 0.4 
a A vail able beginning in 2004 
bOther includes entrepreneur, farmer, unemployed, self-employed, and housemother 
c Ascertained from 1987-2010 
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Table 3.3 Association between Prior Placental Abruption and Preeclampsia 
Preeclampsia 
Controls 
Prior Placental Abruption Cases 
(n=6,487) 
(n=25,948) 
n(%) n(%) 
Any Previous Pregnancl 67 (1.0) 140 (0.5) 
Preterm ( <3 7 weeks) 43 (0.7) 64 (0.2) 
Term (?:..3 7 weeks) 22 (0.3) 73 (0.3) 
Immediately Prior Pregnancya 45 (0.7) 84 (0.3) 
Preterm ( <3 7 weeks) 31 (0.5) 36 (0.1) 
Term (2:3 7 weeks) 13 (0.2) 47 (0.2) 
No Prior Abruption 6420 (99.0) 25808 (99.5) 
a Previous placental abruption ascertained from 1987-2010 
b Adjusted for history of preeclampsia 
Odds Ratio (95% Confidence Interval) for 
Preeclampsia 
Unadjusted Adjusted Adjustedc 
1.92 (1.44, 2.58) 1.66 (1.22, 2.26) 1.67 (1.21, 2.31) 
2.70 (1.83,3.98) 2.18 (1.45, 3.30) 2.21 (1.43, 3.41) 
1.21 (0.75, 1.95) 1.12 (0.68, 1.84) 1.10 (0.66, 1.66) 
2.15 (1.50, 3.10) 1.93 (1.32, 2.83) 1.91 (1.28, 2.86) 
3.46 (2.14, 5.60) 2.82 (1.69, 4.70) 2.78 (1.62, 4.77) 
1.12 (0.60, 2.06) 1.14 (0.61, 2.14) 1.11 (0.57, 2.17) 
1. 00 (Reference) 1. 00 (Reference) 1. 00 (Reference) 
c Adjusted for maternal age, parity, BMI (with imputation), smoking during pregnancy, history of preeclampsia, chronic 
hypertension, and preexisting diabetes 
V'l 
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Table 3.4 Associations between Placental Abruption in a previous pregnancy with and without a History of Preeclampsia, and 
Preeclampsia 
Prior Placental Abruption and 
Prior Preeclampsia 
Preterm Abruption 
Preeclampsia 
No preeclampsia 
Term Abruption 
Preeclampsia 
No preeclampsia 
Preeclampsia and no prior abruption 
No Prior Abruption or Preeclampsia 
Preeclampsia 
Cases 
(n=6,487) 
n(%) 
17 (0.3) 
26 (0.4) 
3 (0.0) 
19 (0.3) 
1068 (16.5) 
5352 (82.5) 
Controls Odds Ratio (95% Confidence Interval) for 
(n=25,948) Preeclampsia 
n (%) Unadjusted Adjusted a 
4 (0.0) 19.85 (6.68, 59.02) 16.57 (5.34, 51.43) 
60 (0.2) 2.02 (1.28, 3.21) 2.09 (1.29, 3.40) 
6 (0.0) 2.35 (0.59, 9.39) 2.12 (0.50, 9.12) 
67 (0.3) 1.33 (0.80, 2.21) 1.35 (0.78, 2.33) 
807 (3.1) 6.18 (5 .61 , 6.80) 5.63 (5 .07, 6.24) 
25,001 (96.4) 1.00 (Reference) 1. 00 (Reference) 
a Adjusted for maternal age, parity, smoking during pregnancy, imputed BMI, chronic hypertension and preexisting diabetes 
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Table 3.5 Association between Placental Abruption and Preeclampsia, Stratified by Interpregnancy Interval, Prior Birth Only 
Interpregnancy interval (IPI) 
IPI <3 years 
Preterm placental abruption 
Term placental abruption 
No Abruption 
IPI 2:3 years 
Preterm placental abruption 
Term placental abruption 
No Abruption 
Preeclampsia 
Cases 
(n=5,030) 
n(%) 
17 (0.3) 
5 (0.1) 
3074 (61.1) 
10 (0.2) 
6 (0.1) 
1918 (38.1) 
Controls 
(n=21,492) 
n(%) 
19 (0.1) 
28(0.1) 
15463 (71.9) 
13 (0.1) 
11 (0.1) 
5958 (27.7) 
Odds Ratio (95% Confidence Interval) for 
Preeclampsia 
Unadjusted Adjusted3 Adjustedb 
4.50 (2.34, 8.67) 3.44 (1.69, 7.00) 3.59 (1.67, 7.71) 
0.90 (0.35, 2.33) 0.89 (0.33, 2.39) 0.86 (0.29, 2.57) 
1. 00 (Reference) 1. 00 (Reference) 1.00 (Reference) 
2.39 (1 .05, 5.46) 2.06 (0.87, 4.89) 2.14 (0.87, 5.17) 
1.70 (0.63, 4.59) 1.75 (0.63, 4.82) 1.72 (0.59, 4.98) 
1. 00 (Reference) 1. 00 (Reference) 1.00 (Reference) 
a Adjusted for history of preeclampsia 
b Adjusted for maternal age, parity, smoking during pregnancy, history of preeclampsia, and preexisting hypertension or 
diabetes, imputed BMI 
Table 3.6 Association between Placental Abruption and Early Onset and Late Onset Preeclampsia using a Definition of 34 
weeks 
Placental Abruption 
Any Previous Pregnancl 
Pre term ( <3 7 weeks) 
Term (~3 7 weeks) 
No Previous Abruption 
Controls 
(n=25918) 
n {%) 
140 (0.5) 
64 (0.2) 
73 (0.3) 
25778 (99.5) 
Early Onset Preeclampsia{<34 
weeks) 
Cases Adjusted odds ratiob {n=676) (95% CI) 
n(%) 
15 (2.2) 2.95 (1.61 , 5.41) 
11 (1.6) 4.26 (2.01 , 9.02) 
4 (0.6) 1.81 (0.63, 5.16) 
661 (97.8) 1. 00 (Reference) 
a Previous placental abruption ascertained from 1987-2010 
Late Onset Preeclampsia 
{~34 weeks) 
Cases Adjusted odds ratiob (n=5803) (95% CI) 
n (%) 
52 (0.9) 1.52 (1.07, 2.16) 
32 (0.6) 2.01 (1.25, 3.22) 
18 (0.3) 0.99 (0.56, 1.76) 
5751 (99.3) 1. 00 (Reference) 
b Adjusted for maternal age, parity, smoking during pregnancy, history of preeclampsia, imputed BMI, chronic hypertension 
and preexisting diabetes 
Table 3.7 Association between Placental Abruption and Incident Preeclampsia 
Preeclampsia Cases Controls Odds Ratio (95% Confidence Interval) 
Placental Abruption (n=6487) (n=25,500) for Preeclampsia 
n 0/o n 0/o Unadjusted Adjusted 
Any Previous Pregnancya 47 0.9% 130 0.5% 1.69 (1.21 , 2.36) 1.75 (1.23, 2.50) 
Preterm ( <3 7 weeks) 26 0.5% 60 0.2% 2.02 (1.28, 3.21) 2.04 (1.25, 3.33) 
Term (~3 7 weeks) 19 0.4% 67 0.3% 1.33 (0.80, 2.21) 1.38 (0.80, 2.39) 
No Previous Abruption 5352 99.1% 25001 99.5% 1. 00 (Reference) 1. 00 (Reference) 
a Previous placental abruption ascertained from 1987-2010 
b Adjusted for maternal age, parity, smoking, preexisting hypertension or diabetes, and imputed BMI 
Table 3.8 Association between Placental Abruption in a Previous Pregnancy and Preeclampsia, Removing Controls 
Hospitalized for Hypertension in Pregnancy 
Preeclampsia Cases Controls Odds Ratio (95% Confidence Interval) 
Placental Abruption (n=6487) (n=25,500) for Preeclampsia 
n 0/o n 0/o Unadjusted Adjustedb 
Any Previous Pregnancl 67 1.0 137 0.5 1.93 (1.44, 2.59) 1.70 (1.22, 2.37) 
Preterm ( <3 7 weeks) 43 0.7 61 0.2 2.79 (1.88, 4.12) 2.30 (1.47, 3.59) 
Term (?:.37 weeks) 22 0.3 73 0.3 1.19 (0.74, 1.92) 1.11 (0.65, 1.89) 
No Previous Abruption 6420 99.0 25,363 99.5 1.00 (Reference) 1. 00 (Reference) 
a Previous placental abruption ascertained from 1987-2010 
b Adjusted for maternal age, parity, smoking, history of preeclampsia, prior spontaneous abortion, prior induced abortion, 
preexisting hypertension or diabetes, and imputed BMI 
0'1 
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3.8 FIGURES 
Figure 3.1. Odds Ratios for Preeclampsia in Relation to Placental Abruption, Preterm Delivery, and Small for Gestational Age 
in the Preceding Pregnancy 
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4 INTRAUTERINE DEVICE USE AND THE RISK OF PREECLAMPSIA 
4.1 INTRODUCTION 
Due to lack of treatment and unsuccessful therapeutic interventions to treat 
preeclampsia, the focus of research in this area has turned to modifiable risk factors prior 
to pregnancy. One such potential risk factor is type of contraceptive method. Studies of 
contraceptive methods in relation to preeclampsia risk have focused on barrier and non-
barrier methods, to address hypotheses of cumulative seminal fluid exposure and reduced 
risks of preeclampsia, yet little attention has been given to any specific type of 
contraception. 1 Some existing studies have investigated the association between oral 
contraceptive use prior to pregnancy and the risk of preeclampsia, but results have been 
fl . . 2 3 con 1ctmg. · 
Intrauterine devices (IUD) are a method of long-acting reversible contraception 
and are copper containing or hormone releasing, also referred to as an intrauterine 
system. IUD use is common worldwide, with the highest prevalence of usage in several 
Asian and European countries. In the United States, IUD usage is less common, but the 
prevalence is increasing.4 Efforts to reduce misconceptions about the risks associated 
with IUD use in nulliparous women, such as pelvic inflammatory disease and infertility, 
have contributed to a worldwide increase in their popularity. From 2007 to 2009, 
significant increases in the use of IUDs were observed among nearly all subgroups of 
age, race, and education in the United States. IUDs are one of the most effective methods 
of contraception with failure rates of < 1 %. Pregnancies conceived with an IUD in place 
are rare, but have been linked to an increased risk of ectopic pregnancy and spontaneous 
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abortion. 5•6 While the effects of an IUD in-situ on subsequent pregnancy outcomes have 
been described, the effects of IUD use and removal prior to pregnancy have not been well 
studied. 
Copper containing and hormone-releasing IUDs both alter the cytokine profile of 
the endometrium and prevent endometrial proliferation. If the presence of an IUD causes 
some endometrial damage, it may be hypothesized that such injury could affect future 
implantation and placentation. There is evidence that some level of decidual injury 
actually increases the invasion potential of trophoblastic cells 7. The association between 
prior use of IUDs, timing of removal, and preeclampsia risk, however, remains unknown. 
The objective of this study was to investigate the association between prior IUD use, 
timing of removal, and the risk of preeclampsia using data from the United Kingdom's 
Clinical Practice Research Datalink (CPRD). 
4.2METHODS 
4.2.1 Source Population 
We conducted a case-control study nested within the Clinical Practice Research 
Datalink (CPRD) from 1993 through 2010. The CPRD, maintained by the Boston 
Collaborative Drug Surveillance Program (BCDSP), is a medical record database that 
was established in 1987 and represents approximately 5% of the population ofthe United 
Kingdom. The database contains medical record information from general practitioners 
(GP), prescription drug data, and referral information. It is estimated that approximately 
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90% of diagnoses from hospital discharge letters are recorded in the database. Measures 
to ensure the quality and validity of the data at the BCDSP are in place. 8 
From the CPRD we identified all singleton pregnancies resulting in a live or 
stillbirth of at least 20 weeks ' gestation. We restricted the study population to deliveries 
with at least 15 months of recorded medical history prior to the delivery date (to have 
adequate exposure information). The CPRD had 556,739 recorded pregnancies from 1993 
through 2010 meeting these criteria. 
4.2.2 Case Definition 
We identified cases of first time preeclampsia from 1993 through 201 0 using 
diagnostic codes in the CPRD. If a woman experienced preeclampsia in multiple 
pregnancies during her follow-up , only the first occurrence was included. Cases included 
pregnancies affected by preeclampsia, eclampsia, HELLP syndrome, and preeclampsia 
superimposed on preexisting hypertension. Gestational hypertension and unspecified 
hypertension during pregnancy were not included as cases. Among the 556,739 eligible 
pregnancies, 2,960 cases of preeclampsia were identified. 
Control pregnancies were those with no history of preeclampsia prior to the index 
date in the CPRD. Four controls were matched to each case on general practice, year of 
birth, and maternal age(+/- 2 years). Women may have contributed more than one 
control pregnancy (n=180). Cases with no successfully matched controls (n=48) were 
excluded. 
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4.2.3 Intrauterine Device Use 
Intrauterine device (IUD) use prior to the start of pregnancy was determined using 
procedure codes, drug codes and manual record review. Procedure codes indicating IUD 
insertion, removal, follow-up, or complications and drug codes indicating the receipt of 
an IUD at any point from the start of the patient record through the date of delivery were 
used to identify subjects using an IUD. IUD use was defined as any IUD receipt prior to 
the index pregnancy without an intervening pregnancy. 
The interval between IUD removal and the start of pregnancy was calculated by 
subtracting the date of IUD removal from the pregnancy start date. The pregnancy start 
date was defined as the date of the last menstrual period (LMP). Approximately half of 
all deliveries in the CPRD have a recorded LMP date. For deliveries that did not have an 
LMP date, but had an estimated date of delivery (EDD), the start date of pregnancy was 
calculated by subtracting 280 days from the EDD. Start date of pregnancy for 
pregnancies without a LMP or EDD (51.6%) was estimated by subtracting 280 days from 
the date of delivery. If an IUD removal date was not recorded, the last recorded date of an 
IUD procedure code was used to calculate the timing of removal. Subjects with an IUD 
procedure code after the start date of pregnancy were categorized as having an IUD in-
situ at the start of pregnancy. Timing of removal was categorized as in-situ, <12 months, 
and ~ 12 months. 
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4.2.4 Covariates 
Information on body mass index (BMI) and smoking prior to the start date of 
pregnancy was collected. BMI (kg/m2) was categorized as underweight ( <18.5), normal 
weight (18.5-24.9), overweight (25-29.9), and obese (2:30). Smoking was categorized as 
ever or never. Data on chronic hypertension, preexisting diabetes and fertility problems 
and treatment, prior to the start date of the study pregnancy were collected. Preexisting 
hypertension was defined as a diagnosis of hypertension in addition to at least one 
prescription for an antihypertensive drug prior to the pregnancy start date. The covariate 
parity was estimated by identifying the number of deliveries resulting in a stillbirth or 
live birth prior to the study pregnancy, categorized as 0 or 2:1. 
4.2.5 Statistical Analysis 
The distributions of demographic and reproductive characteristics were calculated 
for cases and controls. IUD use was examined as a dichotomous variable, any use vs. no 
use. Among IUD users, the timing of removal in relation to the pregnancy start date was 
also examined. Conditional logistic regression models, accounting for the matched study 
design, were used to calculate odds ratios (OR) and 95% confidence intervals (CI). 
Unconditional logistic regression models yielded similar results, indicating no 
confounding by the matched variables, therefore unconditional models were used in sub-
analyses to improve precision. Confounders were identified a priori based on associations 
with both IUD use and preeclampsia and included pre-pregnancy (BMI), smoking, and 
history of hypertension, diabetes, or fertility problems. BMI and smoking information 
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were missing for approximately 25% and 15% of subjects, respectively. Multiple 
imputation methods using 1 0 imputed datasets were utilized to impute missing 
information on BMI and smoking. Variables used to impute missing data included 
maternal age, birth year, prior deliveries, hypertension, diabetes, fertility problems, 
infertility treatment, preeclampsia, and IUD use. 
Nulliparity, or no prior deliveries, is an established risk factor for preeclampsia. 
Additionally, nulliparous women are less likely to use an IUD as a method of 
contraception. 9 Data on parity is unavailable in the CPRD, but the number of prior 
deliveries recorded for a woman can be tallied. Due to the potential for parity to confound 
the relationship between IUD use and preeclampsia, the impact of confounding was 
assessed in several ways. Multiple imputation methods, described above, were used to 
impute nulliparity. Women with prior recorded deliveries could accurately be classified 
as parous (nulliparity=O), while women without a prior delivery may have been 
nulliparous or may have had a prior delivery unrecorded in the CPRD. Among this latter 
group, women that had a record beginning in adolescence without a recorded delivery 
were considered nulliparous (nulliparity=l); parity for all remaining women was 
imputed. The impact of confounding by nulliparity was also assessed using a quantitative 
bias analysis for an unmeasured confounder.10 
A stratified analysis to assess effect measure modification by prior deliveries was 
performed among all women and then among women with a minimum of 1 0 years of 
active follow-up allowing for more complete information on prior deliveries. Effect 
measure modification by pre-pregnancy BMI was also assessed by stratifying on <25 
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kg/m2 or ~25 kg/m2 and comparing differences in measures of association. Women with a 
missing BMI measurement were excluded from the stratified analysis. 
Several sensitivity analyses were also performed. To address the potential for 
misclassification of timing of IUD removal in relation to the pregnancy start date, we 
restricted the analysis to those with a recorded LMP and an exact IUD removal date. 
Additionally, to address concerns about differences between women seeking 
contraceptive care from family planning clinics, which would not be captured in the 
CPRD, and women using their GPs for contraception, an analysis restricted to women 
with a GP recorded contraceptive related visit or prescription in the three years prior to 
the pregnancy start date was conducted. Contraceptive related codes included those 
relating to oral contraceptive pills, injectable contraceptives, subcutaneous contraceptive 
implants or patches, diaphragms, spermicides, and cervical caps. 
4.3 RESULTS 
There were a total of 2,83 7 preeclampsia cases and 11,221 controls included in 
this analysis. Compared to controls, cases were more likely to be overweight (22.9% vs. 
19.5%) and obese (17.5% vs. 10.7%). Pre-pregnancy BMI measurements were recorded 
on average, 2.3 years prior to the pregnancy start date, with approximately 45% of 
subjects having a measurement within 2 years of the pregnancy start date. Restricting 
data on BMI to those with a measurement recorded within two years prior to pregnancy 
did not change the distributions. Cases were less likely to be ever smokers and less likely 
to have had a prior delivery. Co-morbidities, including preexisting diabetes and chronic 
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hypertension, were more common in cases (Table 4.1). Among controls, IUD users were 
more likely to be older, overweight or obese, and have at least one prior delivery than 
non-IUD users (Table 4.2). 
IUD use prior to pregnancy was slightly less common among cases compared to 
controls (3.2% compared to 4.4%). The aOR for the association between IUD use and 
preeclampsia was 0.85 (95% CI: 0.67, 1.10). Adjustment for imputed parity instead of 
prior deliveries, resulted in a decreased point estimate of0.77 (95% CI 0.61, 0.98). The 
association differed by timing of removal with odds ratios of 0.66 (95% CI 0.46, 0.96) 
among women having an IUD <12 months prior to pregnancy and 0.90 (95% CI 0.64, 
1.27) among women with an IUD 2:12 months before pregnancy (Table 4.3). 
Among women with recorded BMI information, IUD use was more strongly 
associated with a reduced risk of preeclampsia among women with a BMI <25 (aOR 
0.64, 95% CI 0.41, 0.99), than among those with a BMI 2:25 (aOR 0.82, 95% CI 0.58, 
1.15) (Table 4.4 ). 
Effect measure modification by any prior deliveries recorded in the CPRD was 
assessed. The odds ratio for IUD use and preeclampsia was 0.66 (95% CI 0.46, 0.95) 
among women with no prior deliveries recorded in the CPRD, while the association 
among parous women was null. Approximately 22% of cases and 20% of controls had 
2:10 years of recorded information in the CPRD prior to the study pregnancy. Analyses 
restricted to those with 2:10 years of follow up showed little effect measure modification 
by prior deliveries, with IUD use being associated with a reduced risk of preeclampsia, 
regardless of prior deliveries (Table 4.5). Quantitative bias analyses varying the 
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prevalence of nulliparity among IUD users and non-users were conducted. Under several 
plausible scenarios, assuming a 2-fold increase in risk of preeclampsia among nulliparous 
women, the odds ratio for the association between IUD use and preeclampsia was 
attenuated upon adjustment for parity, although point estimates largely remained less than 
1.0 (Table 4.6). 
To address the potential for misclassification of IUD removal, analyses restricted 
to women with a recorded LMP and a recorded IUD removal date were performed. 
Among those with an IUD, 30% of cases and 32% of controls had a recorded LMP and a 
recorded removal date. The association between any IUD use and preeclampsia was 
similar to the primary analysis, while the results for timing of removal demonstrated a 
clearer dose-response pattern (Table 4. 7). 
Nearly 70% of both cases and controls had a record of contraceptive use within 
three years of the study pregnancy. Among women consulting with their GP for 
contraceptives, IUD use was associated with a reduced risk of preeclampsia (OR 0.71, 
95% CI 0.55, 0.93). 
4.4 DISCUSSION 
IUD use prior to pregnancy was associated with a small decrease in the risk of 
preeclampsia. The protective effect of IUD use on preeclampsia was most pronounced 
among women with an IUD in-situ and women using an IUD within 1 year of pregnancy. 
To our knowledge this is the first study to investigate IUD usage and timing of removal 
in relation to risk of preeclampsia. 
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In the present study we report a 50% reduction in the risk of preeclampsia for 
women with an IUD in-situ, although our finding is based on just 2 exposed cases with 
recorded information on both IUD removal and LMP. Despite small numbers, this 
finding is consistent with a study performed in a cohort of South American women that 
reported a 40% decreased risk of preeclampsia among women with an IUD in-situ at the 
time of conception. 11 Another study reported a lower frequency of mild and severe 
preeclampsia among women conceiving with an IUD in place than those without an 
IUD, 12 although no measures of association were calculated. The mechanism through 
which IUD use reduces the risk of preeclampsia may be through a process involving 
endometrial injury. IUD use causes some level of mechanical injury to the endometrium 
as evidenced by a chronic inflammatory response to copper IUDs and an altered cytokine 
profile to both copper and hormonal IUDs. Endometrial injury has been demonstrated to 
improve implantation and subsequent placentation among populations undergoing 
assisted reproductive technologies.13 The observed null associations between IUD use 
more than one year before the study pregnancy indicates that any effect of IUD use on 
preeclampsia wanes over time. The effects of IUD use on the endometrium may differ by 
type of IUD and subsequently may have different implications on preeclampsia risk. 14 
Due to limitations of the present study we were unable to assess whether associations 
with preeclampsia differed by IUD type. 
The prevalence ofiUD use among controls was 4.4% from 1993 to 2010, which is 
similar to the contraceptive prevalence in the UK of 4-6% reported from 1993-1995, but 
less than that of 10-11% reported from 2007-2009. 15 In addition to a patient's general 
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practice, contraceptives can be obtained through family planning clinics in the UK. The 
use of family planning clinics in the UK has been declining. In 2010, approximately 10% 
of women in the UK utilized clinics for their contraceptive method. 16 While women may 
have utilized clinics for IUD procedures, restricting the analysis to women with GP 
recorded contraceptive information did not alter the study results. 
The prevalence of preeclampsia among singleton pregnancies in the CPRD from 
1993-2010 was 0.5%, which is less than the estimated 4% among nulliparous women and 
1.7% among parous women from a Swedish study, 17 and an overall prevalence of 3.8% in 
the United States. 18 A review of validation studies of diagnoses in the CPRD reported a 
median positive predictive value of 89% across 183 diagnoses. 19 Although reproductive 
and perinatal diagnoses were not included, hospital discharge registers report positive 
predictive values of 71%-74% and specificities of greater than 99% for diagnoses of 
preeclampsia.20'21 While under ascertainment of preeclampsia cases is likely in the 
CPRD, the specificity is expected to be high, reducing the number of false positives. 
A limitation of this study is lack of information on parity. Several analyses were 
performed to address the potential impact of confounding by parity on our findings. 
Adjustment for prior deliveries, utilized as a proxy for parity, attenuated our findings, but 
point estimates for IUD use in-situ and <12 months prior to pregnancy indicated a 29% 
and 35% reduction in risk of preeclampsia, respectively. Utilizing this proxy likely 
overestimated the prevalence ofnulliparity, given the potential for women to have had a 
prior delivery that was not captured by the CPRD, and therefore the attenuation of odds 
ratio closer to the null value would have been exaggerated. Multiple imputation methods 
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were also utilized to impute and adjust for parity, similarly resulting in an attenuated but 
still protective effect of IUD use on preeclampsia. Lastly, the results of a quantitative bias 
analysis demonstrated that under several plausible scenarios ofthe prevalence of 
nulliparity among IUD users and non-users, the association between IUD use and 
preeclampsia was attenuated, but not completely accounted for by adjustment for parity. 
Only in extreme scenarios of prevalence of nulliparity, which would be unlikely given the 
observed data, was the association between IUD use and preeclampsia completely 
explained by parity. Effect measure modification by parity was less clear. Among women 
with 2:10 years of recorded history in the CPRD, and therefore a more complete 
pregnancy history, a protective effect ofiUD use on preeclampsia was observed 
regardless of parity. Approximately 27% ofwomen aged 35 years and older with at least 
10 years of follow up had no recorded prior deliveries, which is similar to the estimated 
20% of deliveries among women older than 35 being first-borns. 
Incomplete and inaccurate recording of dates in the CPRD should also be noted as 
a limitation. A LMP date was recorded for approximately half of the pregnancies 
included. Sensitivity analyses restricted to women with the most accurate dates for 
pregnancy and IUD use strengthened results indicating that misclassification of timing of 
removal attenuated our results. Inaccuracies in dating also limited our ability to 
distinguish between early-onset and late-onset preeclampsia, which have been suggested 
to be different conditions, as information regarding preeclampsia was recorded at the 
time of delivery or receipt of the hospital discharge information. 
Strengths of this study include a large sample of pregnancies and physician 
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recorded data. From 1993-2010 the CPRD contained records for over half a million 
pregnancies that met the inclusion criteria of the present study. In the United Kingdom 
health care coverage is universal and general practitioners play an integral role in 
maternity care; pre-conception, antenatal, and postpartum.22 Therefore pregnancies 
included in the CPRD were not selected based on type of service utilization. Information 
in the CPRD is recorded by trained general practitioners thereby eliminating reliance on 
self-reported information on exposure, outcome, and covariates. 
4.5 CONCLUSIONS 
In conclusion, IUD use prior to pregnancy was associated with a small reduction 
in the risk of preeclampsia. The recency of removal impacted findings, indicating that the 
timing of IUD use in relation to pregnancy may offer insight into the etiology of 
preeclampsia. Due to the small number of IUD users and incomplete data on confounders 
in the present study, future studies are needed to provide a better understanding of the 
association between IUD use and preeclampsia. 
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4.7 TABLES 
Table 4.1 Characteristics of Preeclampsia Cases and Controls in the Clinical Practice 
Research Datalink, 1993-2010 
Preeclampsia 
Controls 
Cases 
(n=2,837) 
(n=l1,221) 
n 0/o n 0/o 
Body-mass index (kg/m2) 
Underweight ( < 18.5) 56 2.0 355 3.2 
Normal (18 .5-24.9) 965 34.0 4662 41.5 
Overweight (25-29.9) 651 22.9 2193 19.5 
Obese (2: 30) 496 17.5 1204 10.7 
Missing 669 23.6 2807 25 .0 
Smoker 
Ever 917 32.3 4143 36.9 
Never 1518 53.5 5381 48 .0 
Missing 402 14.2 1697 15.1 
Prior deliveries in CPRD3 
0 2036 71.8 5440 48.5 
2:1 801 28.2 5781 51.5 
Preexisting diabetes 49 1.7 62 0.6 
Chronic hypertension 93 3.3 65 0.6 
Fertility problems 334 11.8 1134 10.1 
Mean SD Mean SD 
Maternal age 29.0 6.1 29.2 5.8 
aNumber of prior deliveries (still birth or live birth) recorded in the CPRD 
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Table 4.2 Characteristics ofiUD Users and IUD Non-Users among Controls, 1993-2010 
IUD Use No IUD Use 
n=493 n=10,728 
n 0/o n 0/o 
Body-mass index (kg/m2) 
Undetweight (< 18.5) 8 1.6 347 3.2 
Normal (18.5-24.9) 197 40.0 4465 41.6 
Overweight (25-29.9) 111 22.5 2082 19.4 
Obese(~ 30) 72 14.6 1132 10.6 
Missing 105 21.3 2702 25.2 
Smoker 
Ever 216 43.8 3927 36.6 
Never 226 45.8 5155 48.1 
Missing 51 10.3 1646 15.3 
Prior deliveries in CPRDa 
0 142 28.8 5298 49.4 
~1 351 71.2 5430 50.6 
Preexisting diabetes 4 0.8 38 0.4 
Chronic hypertension 7 1.4 48 0.4 
Fertility problems 22 4.5 820 7.6 
Mean SD Mean SD 
Maternal age (years) 31.0 4.9 29.1 5.8 
aNumber of prior deliveries (still birth or live birth) recorded in the CPRD 
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Table 4.3 Association between IUD Use and Preeclampsia 
Cases Controls Unconditional OR Conditional Odds Ratios (95% Confidence Interval) 
(n=2,837) (n=11,221) (95% CI) for Preeclampsia 
n(%) n (%) Unadjusted Unadjusted Adjusted a Adjustedb 
IUD Use 
Yes 92 (3.2) 493 (4.4) 0.73 (0.58, 0.92) 0.74 (0.59, 0.93) 0.85 (0.67' 1.1 0) 0.77 (0.61, 0.98) 
No 2745 (96.8) 10728 (95.6) 1. 00 (Reference) 1.00 (Reference) 1. 00 (Reference) 1.00 (Reference) 
Duration since removal 
In-situ 7 (0.2) 45 (0.4) 0.61 (0.27, 1.35) 0.60 (0.27, 1.33) 0.85 (0.37, 1.95) 0. 70 (0.31' 1.59) 
<12 months 37 (1.3) 241(2.1) 0.60 (0.42, 0.85) 0.61 (0.43, 0.87) 0.80 (0.55, 1.16) 0.66 (0.46, 0.96) 
2:12 months 48 (1. 7) 207 (1.8) 0.91 (0.66, 1.24) 0.91 (0.66, 1.26) 0.92 (0.65, 1.29) 0.90 (0.64, 1.27) 
a Adjusted for BMI (with imputation), smoker (with imputation), prior deliveries, chronic hypertension, fertility problems, and 
freexisting diabetes 
Adjusted for BMI (with imputation), smoker (with imputation), parity (with imputation), chronic hypertension, fertility 
problems, and preexisting diabetes 
00 
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Table 4.4 Association between IUD Use, Timing of Removal, and Preeclampsia, Stratified by BMI, 1993-2010 
Underweight/Normal Overweight/Obese 
(BMI <25 kg/m2) (BMI ~25 kg/m2) 
Cases Controls Adjusted ORa Cases Controls Adjusted ORa 
(n=1,021) (n=5,017) (95% CI) (n=1,147) (n=3,397) (95% CI) 
n (%) n (%) n(%) n (%) 
IUD Use 
IUD 26 (2.5) 205 (4.1) 0.64 (0.41 , 0.99) 47 (4.1) 183 (5.4) 0.82 (0.58, 1.15) 
No IUD 995 (97.5) 4812 (95 .9) 1.0 (Reference) 1100 (95 .9) 3214 (94.6) 1.0 (Reference) 
Timing of Removal 
In-situ 2 (0.2) 19 (0.4) 0.63 (0.14, 2.74) 4 (0.3) 20 (0.6) 0.70 (0.23, 2.08) 
<12 months 11 (1.1) 98 (2.0) 0.54 (0.28, 1.07) 18 (1.6) 93 (2.7) 0.64 (0.37, 1.09) 
2:12 months 13 (1.3) 88 (1.8) 0.74 (0.40, 1.37) 25 (2.2) 70 (2.1) 1.06 (0.68, 1.72) 
3 Unconditionallogistic regression adjusted for maternal age, birth year, smoker (with imputation), parity (with imputation), 
chronic hypertension, fertility problems, and preexisting diabetes 
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Table 4.5 Association between IUD Use, Stratified by Prior Deliveries in the CPRD 
Cases Controls Odds Ratio (95% Confidence 
n=2,837 n=11,221 Interval) for Preeclampsia 
n (%) n (%) Unadjusted Adjusted a 
No Prior Delivery 
IUD 39 (1.4) 142 (1.3) 0.73 (0.51 , 1.04) 0.66 (0.46, 0.95) 
No IUD 1997 (70.4) 5298 (47.2) 1. 00 (Reference) 1. 00 (Reference) 
:::: 1 Prior Delivery 
IUD 53 (1 .9) 351 (3.1) 1.10 (0.81 , 1.48) 1.04 (0.76, 1.41) 
No IUD 748 (26.4) 5430 (48.4) 1. 00 (Reference) 1.00 (Reference) 
Subjects with :::: 10 years of follow up 
Cases Controls Odds Ratio (95% Confidence 
n=616 n=2,235 Interval) for Preeclampsia 
n(%) n (%) Unadjusted Adjusted a 
No Prior Delivery 
IUD 11 (1.8) 35 (1.6) 0.77 (0.39, 1.53) 0.63 (0.30, 1.30) 
No IUD 412 (66.9) 1008 (45.1) 1.00 (Reference) 1.00 (Reference) 
:::: 1 Prior Delivery 
IUD 10 (1.6) 79 (3 .5) 0.77 (0.39, 1.51) 0.79 (0.39, 1.59) 
No IUD 183 (29.7) 1113 (49.8) 1. 00 (Reference) 1. 00 (Reference) 
a Adjusted for maternal age, BMI (with imputation), smoker (with imputation), fertility problems, chronic hypertension, and 
preexisting diabetes 
Table 4.6 Results of Quantitative Bias Analyses Varying Prevalence ofNulliparity 
among IUD Users and Non-Users, Assuming OR=2 for Association between Nulliparity 
and Preeclampsia 
P (Nulliparity/ Nulliparity 
P(Nulliparity/ IUD Non- Adjusted 
IUD Users) Users) Crude OR OR 
0.2 0.88 0.83 
0.05 0.3 0.81 0.90 
0.4 0.75 0.97 
0.5 0.70 1.04 
0.2 0.92 0.80 
0.1 0.3 0.85 0.86 
0.4 0.79 0.93 
0.5 0.73 0.99 
0.2 0.96 0.76 
0.15 0.3 0.88 0.82 
0.4 0.82 0.89 
0.5 0.77 0.95 
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Table 4.7 Odds Ratios for the Association between IUD Use and Preeclampsia, Restricted to Women with a Recorded Last 
Menstrual Period and IUD Removal 
Cases 
(n=1,357) 
n (%) 
IUD Use 
IUD 28 (2.1) 
No IUD 1329 (97.9) 
Timing of Removal 
In-situ 2 (0.1) 
<12 months 16 (1.2) 
::::12 months 10 (0.7) 
Controls 
(n=4,981) 
n (%) 
159 (3.2) 
4822 (96.8) 
19 (0.4) 
98 (2.0) 
42 (0.8) 
Odds Ratio (95% Confidence Interval) for 
Preeclampsia 
Unadjusted Adjusted3 
0.64 (0.43, 0.96) 0.75 (0.49, 1.14) 
1. 00 (Reference) 1. 00 (Reference) 
0.38 (0.09, 1.64) 0.53 (0.12, 2.32) 
0.59 (0.35, 1.01) 0.71 (0.41, 1.23) 
0.86 (0.43, 1.73) 0.91 (0.44, 1.86) 
a Unconditional logistic regression adjusted for maternal age, birth year, BMI (with imputation), smoker (with imputation), 
parity (with imputation), chronic hypertension, fertility problems, and preexisting diabetes 
00 
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Table 4.8 Odds Ratios and 95% Confidence Intervals for Association between IUD Use and Preeclampsia, Restricted to 
Women with a General Practice Contraceptive Visit or Prescription 
Cases Controls Odds Ratio (95% Confidence Interval) 
(n=1,960) (n=7,783) for Preeclampsia 
n (%) n(%) Unadjusted Adjusted a 
IUD Use 
Yes 72 (3.7) 409 (5.3) 0.69 (0.53, 0.89) 0.71 (0.55, 0.93) 
No 1888 (96.3) 7374 (94.7) 1.00 (Reference) 1.00 (Reference) 
Timing of Removal 
In-situ 7 (0.4) 43 (0.6) 0.64 (0.29, 1.42) 0.72 (0.32, 1.63) 
<12 months 37 (1.9) 238 (3.1) 0.61 (0.43, 0.86) 0.64 (0.45, 0.93) 
2.12 months 28 (1.4) 128 (1.6) 0.85 (0.57, 1.29) 0.83 (0.53, 1.28) 
a unconditional logistic regression adjusted for maternal age, birth year, BMI (with imputation), smoker (with imputation), 
parity (with imputation), chronic hypertension, fertility problems, and preexisting diabetes 
5 CONCLUSIONS 
Despite decades of research, preeclampsia remains a disease of theories. The 
etiology remains elusive, risk prediction models prove inaccurate, and therapeutic and 
prophylactic interventions are disappointing. This obstetrical complication is a major 
contributor to preterm delivery, given the only effective cure is delivery of the placenta. 
This doctoral thesis was aimed at exploring a hypothesis involving endometrial injury as 
a mechanism for reducing the subsequent risk of preeclampsia. While endometrial injury 
would best be measured using biologically relevant markers, exposures that have been 
suggested to temporarily alter the homeostasis of the endometrium were instead explored. 
The development of this hypothesis was driven by a body of literature citing 
improvement in implantation after local injury to the endometrium. 1•2 
The main findings of this thesis include reduced risks of preeclampsia among 
nulliparous women following induced abortion and among women using an IUD prior to 
pregnancy. We also observed an increased risk of preeclampsia among women with a 
prior preterm placental abruption, but not among women with a history of term placental 
abruption. We hypothesized that term placental abruption, which may have a different 
etiology than that underlying both preterm abruption and preeclampsia, would be 
associated with a reduced risk of preeclampsia. In our primary analysis we observed null 
associations between term placental abruption and preeclampsia, but point estimates were 
less than one in secondary analyses restricted to women with a short interpregnancy 
interval (<3 years). In all three studies we observed stronger protective associations as the 
duration between the exposure and the start of the study pregnancy decreased, suggesting 
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that the role of endometrial injury, if any, in reducing the risk of preeclampsia may have a 
time-sensitive effect. 
Several methodological issues were raised throughout the course of this work. 
While study design considerations and analytic strategies were carefully implemented to 
reduce bias, limitations of the data still exist. The exposures explored in these analyses 
are all relatively rare with exposure prevalence of <1% for placental abruption, 5% for 
IUD use, and 12% for induced abortions. Rare exposures coupled with a rare outcome 
presented us with small numbers of exposed cases in all three studies, which in turn 
yielded imprecise confidence intervals for several of the measures of associations 
presented. Small numbers did not have implications on systematic error, but an increased 
amount of random error was introduced. 
Another recurrent limitation was outcome misclassification. The prevalence of 
preeclampsia in the Finnish registry data was comparable to that of other Nordic 
countries, while the CPRD underestimated the expected prevalence of preeclampsia. 
Considered a severe obstetrical complication, preeclampsia was likely recorded with very 
high specificity, mitigating some of our concerns regarding disease misclassification. 
Furthermore preeclampsia represents a spectrum of conditions and the fine gradations of 
the disease were challenging to capture in all ofthe studies conducted. A growing body 
of literature advocates for distinction between early-onset preeclampsia and late-onset 
preeclampsia, as these may be etiologically different conditions.3 We address this to some 
extent in the studies utilizing the Finnish registry data, but this level of detail could not be 
captured in the study utilizing the CPRD due to inadequate timing information. 
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Additionally, accruing evidence suggests that preeclampsia superimposed on chronic 
hypertension, which was difficult to tease out in the datasets utilized, has a differing set 
of risk factors than the de novo onset of hypertension during pregnancy. If the impact of 
endometrial injury from the exposures explored has a differing effect based on timing of 
onset or subtype of preeclampsia, we were unable to capture it. 
At several points in this thesis, we report differences in measures of association 
based on elements of pregnancy timing, firstly, the IPI between an induced abortion and a 
subsequent pregnancy, secondly, the IPI between an abruption affected pregnancy and a 
subsequent pregnancy, and lastly, the timing of removal of an IUD before the start of a 
pregnancy. What we were not able to assess were several behavioral factors, such as 
partner change and pregnancy intention, and reproductive factors, such as sub-fecundity 
and infertility, which may serve as explanations for these intervals of time. Whether 
factors, such as those suggested above, account for the differences observed could not be 
assessed. Lack of information introduced the possibility of confounding. Issues with 
confounding also presented themselves with issues of parity. In the first two studies 
confounding by parity was addressed through restriction, but was more problematic in the 
CPRD. Preeclampsia has been coined a "disease of first pregnancies" due to 2 to 4-fold 
increases in risk among nulliparous women compared to parous women. Given these 
differing risk profiles, future studies should include detailed reproductive history 
information. 
Translating the findings of this research into a public health message is difficult, 
and arguably unwarranted, given the non-modifiable nature of some of the exposures 
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explored. While there is not a take away public health message from this body of work, 
the aim was to provide a contribution to the literature exploring causal mechanisms 
involved in the development of preeclampsia. This thesis was specifically designed to 
address a research question involving the role of endometrial injury as a mechanism to 
reduce the risk of preeclampsia. Several findings reported in this thesis have not 
previously been explored, particularly those involving exposures ofpreterm and term 
placental abruption and IUD use. In addition to suggesting that endometrial injury may 
have a role in the development of preeclampsia, we simultaneously provide support for 
other circulating hypotheses. Our findings regarding history of induced abortion and 
reduced risk of preeclampsia are consistent with that of the fetal antigen exposure 
hypothesis.4 Additionally, we report an elevated risk of preeclampsia following a 
pregnancy affected by preterm placental abruption, but not for term placental abruption. 
This supports a hypothesis of heterogeneity between conditions of ischemic placental 
disease based on preterm and term gestations. 5 Accompanying the aforementioned 
limitations, these studies also had several strengths and provide new findings. Future 
studies should be designed to quantify endometrial injury to better address our proposed 
hypothesis. 
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